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ABSTRACT OF THE DISSERTATION
SYNTHESIS OF ANTIMICROBIAL POLYMERS TO OVERCOME
ANTIMICROBIAL RESISTANCE
by
Md Salauddin Ahmed
Florida International University, 2018
Miami, Florida
Professor Joong Ho Moon, Major Professor
Drug-resistant pathogens are emerging rapidly and thwart the treatment of common
bacterial infectious diseases that can lead to death. Many contagious diseases remain
difficult to treat because of acquired drug resistance. Compared to small antibiotics, which
interrupt the intracellular biochemical processes, antimicrobial polymers with relatively
high molecular weights offer a promising strategy to overcome drug resistance by
disrupting the physical integrity of the membrane. Because of the unique mechanism,
bacteria need a much longer time to develop resistance.
A new class of antimicrobial polymer in which the positive charge and
hydrophobic/hydrophilic units are linearly connected in the amidinourea backbone was
designed, synthesized, and tested for various bacteria including methicillin-resistant
Staphylococcus aureus (MRSA). We evaluated the effects of hydrophobicity and polymer
molecular weights on antimicrobial activity by measuring minimum inhibitory
concentrations (MIC) and hemolytic activities (HC50). Amidinourea antimicrobial
polymers exhibit a promising MIC90 value (13 μg/mL) with low HC50, resulting in high
selectivity (HC50/MIC90) against MRSA.
vii

Many bacteria have developed resistance against Ciprofloxacin. To overcome the
antibiotic resistance associated with Ciprofloxacin, we hypothesized that a steady release
of Ciprofloxacin at the bacteria membrane can overcome the drug resistance because the
local drug concentration can be overwhelmingly high to suppress the drug efflux pump
expressed on the membrane. A series of homo and di-block copolymers containing
Ciprofloxacin, as the form of prodrugs, was synthesized using ring-opening metathesis
polymerization (ROMP), and we evaluated their antimicrobial efficacy. While homo
polymers only containing Ciprofloxacin were inactive against almost all bacteria tested,
di-block copolymers containing Cipro and triphenylphosphine exhibited some
antimicrobial activity against wild type M. smegmatis.
Modulation of chemical environments at the positively charged polymeric materials can
significantly influence the biophysical properties required for efficient cellular interaction
and subsequent entry. Using intrinsic fluorescent conjugated polymers (CPs), we have
demonstrated that the modulated guanidine group with various hydrophilic or hydrophobic
moieties dramatically changed their cellular behaviors. We prepared a series of modified
guanidine-containing CPs and examined their cellular behaviors by using confocal
microscopic imaging. Details of the modification chemistry and modification-dependent
cellular behaviors and a knockdown of a target protein in primary cells were discussed.
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CHAPTER I: INTRODUCTION
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1.1. General Introduction to Antimicrobial Resistance
Antimicrobial resistance is a worldwide problem for both human and animal health.
In 2013, approximately two million people acquired a serious infection, and 23,000 people
died as a direct consequence of antibiotic-resistant infection in the United States[1, 2]. The
cost of caring for patients with antimicrobial resistance has exceed around $4 billion each
year in the United States[1, 2].

Figure 1.1. Antimicrobial-resistant bacteria sharing their genetic materials with the other
bacteria and increasing antibiotic resistance[1].
Several health-related associations, including the World Health Organization
(WHO), have declared antimicrobial resistance one of the most dangerous threats to human
health[1]. Antimicrobial-resistant bacteria can exchange their DNA with other similar or
different types of bacterial species and thus also make them antibiotic resistant, which
results in multidrug-resistant bacteria[3] (Figure 1.1). The bacterial resistance appears to
be the result of one of the three mechanisms: (1) alteration in the antibiotic enzymatic
target, (2) decreased outer membrane permeability, and (3) the development of the efflux
mechanism (Figure 1.2)[4, 5]. For example, fluoroquinolone antibiotics such as
Ciprofloxacin work against cell membrane synthesis. They primarily inhibit the growth of
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bacterial gyrase, an enzyme responsible for DNA repair[1]. The Ciprofloxacin loses its
activity because of the bacteria’s development of the efflux mechanism.
This dissertation focuses on development of antimicrobial polymers to overcome
antimicrobial resistance. More precisely, in Chapter 2 discusses the synthesis of
antimicrobial polymers using amidinourea functional group to overcome multidrug
resistance, and Chapter 3 presents a synthesis of Cipro-containing antimicrobial polymers
in a pro-drug approach to overcome the efflux mechanism associated with Ciprofloxacin.
In this introduction, I will provide a general overview of the polymeric approach to
overcome antimicrobial resistance.
1.2. Mechanism of Antimicrobial Resistance
It is now of great concern that a number of resistant bacteria are increasing rapidly
and are becoming resistant to more than one antibiotic. Bacteria can develop resistance to
an existing antimicrobial via several mechanisms (section 1.1).

Figure 1.2. Antimicrobial resistance due to bacterial cell wall. Alteration in the antibiotic
enzymatic target, decreased outer membrane permeability and the development of efflux
mechanism[4]. (edited)
Among them are the efflux mechanism, which evolve when bacteria prevent antibiotics
from entering the cell and immediately kick an antibiotic out of the bacterial cell (Figure
3

1.2). Development of the efflux mechanism appears to be a result of the loss of
antimicrobial concentration at the cell membrane. Each bacterium has a degree of antibiotic
tolerance. Above this antibiotic tolerance limit, bacterial growth will be curbed but will not
kill the organisms. This is called the minimum inhibitory concentration (MIC)[6]. More
generally, bacteria with the efflux mechanism have a higher MIC value than the value
should be.
1.3. Overcome Antimicrobial Resistance
To combat pathogenic infections as well as antimicrobial resistance, antimicrobial
agents known as antibiotics are widely used[7]. The compounds with the biocidal
properties able to inhibit the bacterial growth are called antimicrobial agents. Numerous
efforts have been made in the development of antimicrobial agents to kill or suppress the
microbial grown to battle emerging pathogenic diseases, but success against infectious
diseases remains the same or little improved[8, 9]. Small molecular antimicrobial agents
are fulfilling some of those aims, but their use is limited because of cytotoxicity and longtime efficacy[9, 10]. Antimicrobial polymers, first discovered in 1965[11], are promising
as agents to kill or suppress bacterial growth. Since then, appreciable developments have
been made on antimicrobial polymers.
1.4. Mechanism Action of Antimicrobial Polymers
Bacterial cell walls are structurally different based on their gram strain. Grampositive bacterial cell walls are composed of teichoic acid molecules, whereas
lipopolysaccharides and phospholipids are found in gram-negative bacterial cell
membranes. Gram-negative bacteria have an outer membrane composed of a phospholipid
bilayer. Most of the functional proteins such as enzymes are enclosed in a cytoplasmic
4

membrane of gram-negative bacteria. The cytoplasmic membrane controls the transfer of
solutes and metabolites to enter the cell cytoplasm[12]. The antimicrobial polymers target
the cytoplasmic membrane and are known as membrane-active agents, or antimicrobial
polymers, and are composed of hydrophilic-hydrophobic compounds and cationic charge
on the side chains. These kinds of structures have surface activity properties and
absorption/adsorption ability that can bind with bacterial cells because of the high
lipophilicity present in the cytoplasmic membrane. As a result of cytoplasmic membrane
disruption, leakage of cytoplasmic contents and cell death occur[13].
1.5. Progress in Antimicrobial Polymer Synthesis
Research on antimicrobial polymers has mainly focused on the development of an
easy synthetic method and on improving the antimicrobial properties against resistant
pathogens. As compared to small antimicrobial agents, antimicrobial polymers exhibit
superior efficacy, minimize environmental problems, and reduce toxicity.
There are several ways to synthesize an ideal antimicrobial polymer. Understanding
the bacterial cell wall, outer membrane, and cytoplasmic membrane, a smart design in
monomer and polymer has been developed over recent years. Ring-opening metathesis
polymerization (ROMP) is one of the useful techniques to synthesize mono and block
copolymers. Tew et al. published several articles using ROMP as an efficient method for
synthesizing antimicrobial polymers (Figure 1.3. A & B)[14, 15]. Another technique to
make antimicrobial polymers is the incorporation of antimicrobial agents into a polymer
via a pro-drug approach. In this technique, a well-known antibiotic drug is attached to the
monomer by covalent or ester bond formation (Figure 1.3. C) followed by
polymerization[16]. Conjugated polymers (CPs) are also used as antimicrobial agents.
5

Having a proper balance between hydrophobicity and hydrophilicity along with
incorporation of positive charge on their side chain, CP-based antimicrobial polymers have
been reported to overcome antimicrobial resistance in recent years. In the CP based
method, a rigid hydrophobic aromatic backbone provides necessary hydrophobicity while
the flexible side chain balances the hydrophilicity (Figure 1.3. D)[17].

Figure 1.3. Antimicrobial polymer via ring-opening metathesis polymerization (ROMP)
(A & B), pro-drug approach of Ciprofloxacin (C) and conjugated antimicrobial polymer
(D).
1.6. Design Consideration of Antimicrobial Polymers
Effect of positive charge: The bacterial cell surface is negatively charged, so most
of the antimicrobial polymers contain a positive charge on their side chain[18]. Most
synthetic antimicrobial polymers target pathogens via cationic interaction. Amine,

6

guanidine, and quaternary ammonium are the common sources for positively charged
antimicrobial polymers[19-24]. Figure 1.4 shows the structures of the positively charged
functional groups found in antimicrobial polymers. Among the various sources, protonated
primary and tertiary amines of polycarbonates are more active on microbes[25-27]. Unlike
low molecular weight, primary amines containing polyacrylate, corresponding quaternary
amines do not show antimicrobial activity because of loss of the hydrophobicity required
to disrupt the bacterial cell membrane[28, 29]. Compared to quaternary ammonium,
protonated secondary amine has higher antimicrobial activity[19, 25]. Therefore, primary
and secondary amines may be interacting with the bacterial cell membranes via hydrogen
bonding along with cationic interactions to show better antimicrobial activity. At the same
time, amines are found to be less toxic to human red blood cells, making them the most
functional groups of antimicrobial polymers[21].

Figure 1.4. Common positively charged functional groups in antimicrobial polymers.
Besides amine and quaternary ammonium, guanidine functional groups possess higher
antimicrobial activity on cell membrane of pathogens. Guanidine containing conjugated
poly(norbornene) and polyacrylate have excellent antimicrobial activity[15, 30]. Tew et al.
reported that incorporation of guanidine moiety in antimicrobial peptides (AMPs)
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dramatically increased antimicrobial activity and decreased hemolytic property[15].
Amide bonds in guanidine functional group show strong interaction with the lipid
membranes of microbes via hydrogen bonding and thus show higher antimicrobial
potency[31].
Effect of hydrophobic-hydrophilic balance: Antimicrobial activity of
antimicrobial polymers also depends on a balance between the hydrophobic and
hydrophilic natures of synthetic polymers[32]. The bacteria cell membrane is composed of
hydrophilic, water-filled porin channels and a hydrophobic lipid bi-layer[33-36].
Hydrophobic antibiotics such as rifampicin and fluoroquinolones cross the cell wall
through a diffusion approach[37]. Ikeda et al. reported the highest antimicrobial activity
with the longest chain (C12) of poly(trialkylvinyl-benzylammonium chloride)[38].
Recently, Nonaka et al. investigated the length of methacryloyl-ethyl trialkyl phosphonium
chlorides on E. coli and found antimicrobial activity increased with an increase of the
number of hydrophobic units[39, 40].
To increase hydrophobicity, using alkylation and/or copolymerization with
hydrophobic units is very common. But excess hydrophobicity also increases the hemolytic
activity. To compensate with hemolysis, hydrophilic units are introduced to make a
balanced antimicrobial polymer. For example, polyethylene glycol (PEG) has higher
antimicrobial properties with higher hemolytic activity. Copolymerization of PEG acrylate
with aminohexyl acrylate decreases hemolytic activity, but it also decreases antimicrobial
activity[41]. Thus, an optimal balance between hydrophobicity and hydrophilicity is
essential for an ideal antimicrobial polymer.

8

Effect of polymer chain length: The polymer length plays a crucial role in terms
of achieving the desired antimicrobial properties. Thus, significant research has been
conducted on molecular weight-dependent antimicrobial polymer synthesis. Ikeda et al.
synthesized homo and copolymers of polyacrylate and polymethyl acrylates with biguanide
groups in the side chain[38, 42]. They reported that the biocidal action of synthesized
polymers against S. aureus highly depends on the molecular weight. After analyzing
various molecular weights, they reported the optimal range of most active antimicrobial
polymers as between 5 × 104 and 1.2 × 105 Da. The antimicrobial activity of higher
molecular weight polymers, compared to that of lower ones, can be explained by taking
into consideration the bacterial cell membrane structure. Bacterial cell walls are negatively
charged and susceptible to electrophoresis. Hence, adsorption of higher molecular weight
polymers to the negatively charged cell membrane is expected to be greater than that of
low molecular weight polymers.
In contrast with those of higher molecular weight, lower molecular weight
polymers possess more antimicrobial activity. Tew et al. reported that lower molecular
weight polymers showed better biocidal activity than the higher ones[14]. By analyzing
different length of oligomers while making antimicrobial peptides (AMPs), Tew et al.
reported that a minimum chain length is necessary to obtain any antibacterial activity[14].
1.7. Introduction of Amidinourea Functional Group
Sections 1.1 to 1.6 discussed the definition and mechanism of antimicrobial
resistance and a polymeric approach to overcome antimicrobial resistance. As the goal of
this dissertation is to discuss the synthesis of polymers to overcome antimicrobial
resistance, I will now introduce the actual functional group used in the process.
9

In Chapter 2, I discussed the synthesis of amidinourea containing antimicrobial
polymer and their antimicrobial activities. When Boc guanidine reacts with primary or
secondary amine at an elevated temperature, a new functional
group emerged called amidinourea[43]. Amidinourea contains
features of both guanidine and urea with different physical and
chemical properties. Synthesis of an amidinourea functional group can be achieved by
modification of guanidine group with a primary or secondary amine. Small molecular
amidinoureas and their derivatives have been used in many medicinal chemistry
applications, such as in the treatment of irritable bowel syndrome, gastrointestinal,
spasmolytic, cardiovascular disorders, and parasitic infections. It also possesses good
antimalarial

activity

and

fungicidal

properties[44-47].

Because

amidinourea-

functionalized compounds have been tested for antimalarial and antifungal agents, and
plasmodium has a bacteria-like cell surface, it is expected that amidinourea might have
some antimicrobial activities. Moreover, polymeric materials are successfully used for
overcoming

antimicrobial

resistance.

Hence,

amidinourea-containing

polymers

(polyamidinourea) are expected to have antimicrobial activity on certain bacteria cell
surfaces. Antimicrobial activities depend on the proper balance of hydrophobicity and
hydrophilicity along with positive charge. The amidinourea functional group containing a
new class of polyamidinourea antimicrobial polymers have been designed, synthesized,
and tested on several resistant bacterial cell membranes, including multidrug-resistant
bacteria (e.g., MRSA).
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1.8. Cipro-Containing Antimicrobial Polymer via ROMP
Chapter 3 focuses on the synthesis of Cipro-containing antimicrobial polymer via
ROMP. As discussed earlier, antimicrobial resistance such as efflux pumping appears
because of a low concentration of antibiotics at the bacterial cell membranes. To increase
the local concentration of antimicrobial agents, we have polymerized Ciprofloxacin with
more hydrophobic monomer to combat the efflux pumping-resistant mechanism. We
anticipated that copolymerization of Cipro with more hydrophobic monomer might
increase the antibiotic concentration without increasing the drug percentage. In this
approach, Cipro-containing homo and di-block copolymers have been designed and
synthesized, and their antimicrobial properties are discussed in Chapter 3.

Figure 1.5. Reaction mechanism of ROMP[49].
The ring opening metathesis polymerization (ROMP) reaction is a highly useful
technique to synthesize a very narrow and controlled length of polymers[48, 49]. ROMP is
a ruthenium catalyst-based ring-opening polymerization technique and generally converts
11

cyclic olefins into linear polymers. The reaction mechanisms involve the coordination of a
cyclic olefin into a ruthenium catalyst complex. Later [2+2] cycloaddition produces a
ruthenium-cyclobutane intermediate to form a growing polymer chain[50]. The
intermediate then undergoes cycloreversion to form a new metal alkylidene. The
intermediate steps are repeated during the propagation stage until the monomer is
completely consumed. The ROMP reaction is quenched by an addition of excess ethyl
vinyl ether[50].
1.9. Application of Antimicrobial Polymers
Antimicrobial polymers are widely used in the medical, textile, and food industries.
Medical or medicinal devices are susceptible to microbial infections. Most are from
hospital-acquired infections from medical devices, despite continual improvements in
materials and techniques. The copolymer of 4-vinyl-n-hexylpyridinum bromide and
dimethyl(2-methacryloyloxyethyl) phosphonate helped to reduce biofilm formation and
improved the use of medical devices. A significant reduction of several pathogenic
infections associated with resistant bacteria such as Streptococcus sanguinis, Escherichia
coli, Staphylococcus aureus, and Staphylococcus epidermidis have been achieved by
coating copolymer on titanium[51].
To overcome catheter-associated infections, a combination of rifampicin,
sparfloxacin, and triclosan was developed and a maximum one-month duration of efficacy
was achieved. Antimicrobial polymers are a new class of antimicrobial agent with broad
spectrum and high antimicrobial activity against a variety of pathogens. Antimicrobial
wound-dressing cotton gauze, composed of polycation and polyanion, provide a high
antimicrobial effect for Staphylococcus aureus and Klebsiella pneumonia[51].
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Food safety and quality are important for consumer health. Nisin is the only
currently approved food preservative because of its low toxicity and antibacterial
effectiveness[52]. A great success in packing film has been achieved by incorporation of
preservatives into a polyolefin matrix using glycerol mono-oleate as a dispersant[53].
Textiles are another suitable environment for microbial growth because of their
optimum conditions of temperature and moisture. Antimicrobials for textiles have attracted
numerous attention over the past decades. Eco-friendly antimicrobial textile materials have
been prepared by using polypropylene- and corona-modified polypropylene nonwoven
material with thymol[54].
1.10. Introduction to CPs
Chapters 2 and 3 discuss and present the synthesis of antimicrobial polymer and its
biological assay. Chapter 4 focuses on modification of the guanidine functional group in
CPs and their application in cellular imaging and gene or drug delivery. Conjugated
polymers (CPs) are widely used in biological applications because of their simple synthetic
procedure and easy separation steps. High brightness, excellent photo stability, low
cytotoxicity, high quantum yield, and variable surface charges made CP-based drug
delivery more advantageous than many other gene carriers[55]. Incorporation of specific
recognition elements into CPs adds further ability for targeted recognition and imaging in
vitro and in vivo[56].
1.11. Types of Typical CPs and Polymerization Methods
Among several types of CPs, four major CPs with their synthetic schemes are
depicted in Figure 1.6. Polythiophenes (PTs) and poly(p-phenylenevinylene)s (PPVs) have
been widely used in photonic applications. Poly(p-phenyleneethynylene)s (PPEs) have
13

been used for drug or gene delivery applications[57]. The poor solubility and process
ability of poly(p-phenylenebutadiynylene)s (PPBs) have limited their use in biological
applications. Because Chapter 4 mainly focuses on modulation of guanidine functional
group in (p-phenyleneethynylene) (PPE), I will stick to PPE only. Basically, PPEconjugated polymers are synthesized following the Sonogashira coupling reaction when a
palladium-catalyzed reaction mechanism has been used.

Figure 1.6. Structure of CPs: poly(fluorine) (PF) (A), poly(p-phenylenevinylene) (PPV)
(B), poly(p-phenyleneethynylene) (PPE) (C), and poly(thiophene) (PT) (D)[57-60].
1.12. Guanidine Head Group Modification in CPs
As discussed in section 1.8, Chapter 4 deals with the synthesis and modification of
guanidine containing CPs, and their cellular and subcellular behaviors have been studied
with gene delivery efficacy.
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In Boc-protected guanidine (Boc NHR1), the amide proton is relatively acidic,
which can be deprotonated by a primary or secondary amine to make guanidine-modified
compounds. The reaction mechanism involves in situ generation of isocyanate, which can
further react with nucleophiles to have the guanidine-modified products. Small molecular
guanidine functional group modification has been reported. Kessler et al. modified the
guanidine group of the RGD pentapeptide Cilengitide ligand. The authors demonstrated
that N-methylation, N-alkylation, or N-acylation of Cilengitide enhanced the binding
affinities of the ligands and thus resulted in increased selectivity of Cilengitide
ligands[61]. Takemoto et al. used palladium- or iridium-catalyst to modify guanidinum
in small molecule in a convenient way[62]. Macrocyclic compounds have also been used
in the modification of guanidine moieties, and their applications in the chemical,
biological, and medicinal fields have been documented.
Because guanidine moiety is highly charged and its addition in the CPs’ side chain
triggers cellular entry barriers, we have hypothesized that incorporation of a more
hydrophobic and/or hydrophilic group might possess better cellular transfection as well
as cellular imaging and gene delivery. To do that, we modified a guanidine group in PPE
polymer with more hydrophobic and hydrophilic compounds. Various modified CPs have
been prepared, their cellular and sub-cellular localization have been studied, and these
are presented in Chapter 4.
1.13. Biological Application of CPs
Guanidine containing CPs show good agreement in terms of CP-based drug
delivery vehicles because of their highly positively charged side chain. Moon et al.

15

synthesized amine containing PPE and demonstrated the delivery of biologically active
materials like siRNA into HeLA cells[63].
In addition, positively charged, fluorescent properties of CPs are important in
cellular imaging. As anticipated, CP has excellent photostability with low cytotoxicity and
enters cytoplasm via endocytosis, which can be monitored by confocal microscopy.
1.14. Summary
This dissertation generally focuses on synthesis of various polymeric materials for
antimicrobial resistance or gene or drug delivery. Chapters 2 and 3 discuss the synthesis of
antimicrobial polymers. In this project, we demonstrated the synthesis of antimicrobial
polyamidinourea with an amidinourea functional group in the polymeric backbone.
Chapter 3 discusses the synthetic condition along with antimicrobial assays and their
minimum inhibitory concentrations on several resistant bacterial cell walls. Chapter 4
presents the synthesis of guanidine containing PPE polymers and the modification of the
guanidine head group with different types of amine and alcohol. Later, the modified
polymers were tested for gene delivery and significant protein knockdown was achieved.
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2.1.

Abstract
Drug-resistant pathogens are emerging rapidly and thwart the treatment of common

bacterial infectious diseases that can lead to prolonged illness, disability, and death.
Regardless of the considerable developments made in antimicrobial drugs, many
contagious diseases remain difficult to treat because of acquired drug resistance. Compared
to small antibiotics, which interrupt the intracellular biochemical processes, antimicrobial
polymers with relatively high molecular weights offer a promising strategy to overcome
drug resistance by disrupting the physical integrity of the membrane. Because of the unique
mechanism, bacteria need a much longer time to develop resistance. A new class of
antimicrobial polymers is based on an amidinourea functional group, in which the charges
in the backbone have been designed, synthesized, and tested using bacteria, including
methicillin-resistant Staphylococcus aureus (MRSA). We evaluated the effects of
hydrophobicity and polymer molecular weights on antimicrobial activity by measuring
MIC90 (minimum inhibitory concentration) and HC50 (hemolysis assay). Amidinourea
antimicrobial polymers exhibit a promising MIC value (13 μg/mL) with selectivity of 30
(HC50/MIC90) against MRSA, supporting the concept that the novel functional group has
unique antimicrobial activity. In this research, we discussed a synthetic approach to make
a unique functional antimicrobial polymer and discussed several factors that influence
antimicrobial activity, such as positive charge, hydrophobicity-hydrophilicity balance,
size, and chain length.
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2.2.

Introduction
Microorganisms are primarily responsible for infectious disease, which may come

from resistant bacteria[1]. Infectious diseases kill more people than any other single cause
and becoming a great concern in various fields concerning the infectious qualities of
medical devices, drugs, and hospitals surfaces[2, 3]. In most cases, infections countered
with antimicrobial agents are vulnerable to their action[4, 5]. Bacteria can be resistant to
an antimicrobial agent either by development of the efflux mechanism or alteration in the
antibiotic enzymatic target. The worst-case scenario is that resistant bacteria can share their
DNA with other kinds of microbes and make them antimicrobial resistant as well, which
results multidrug-resistant evolution[6-10].

Figure 2.1. Schematic representation of polyamidinourea antimicrobial polymer
Small molecular antibiotics have been widely used as antimicrobial agents,
disinfectants, and antiseptics; but bacteria can easily mutate the specific targets of small
molecules and result in the formation of drug-resistant microorganism strains.
Additionally, the competency of small molecular antibiotics is poor for long-term
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safety[11]. Therefore, polymeric materials with antimicrobial properties offer good
chances for increasing efficacy[12, 13] because polymeric materials are less toxic, more
efficient and selective, and prolong the lifetime of the antimicrobial agents[14-16].
Antimicrobial polymers can slow or inhibit the progress of drug-resistant microorganism
strains because of their distinctive antimicrobial mechanism[17, 18]. Antimicrobial
polymers are composed of hydrophilic and hydrophobic compounds with cationic charges
on the side chains. These kinds of structures have surface activity properties and
absorption/adsorption ability that can bind with bacterial cells because of the high
lipophilicity present in the cytoplasmic membrane. As a result of cytoplasmic membrane
disruption, leakage of cytoplasmic contents and cell death occurs[13].
Many reports published in the field of polymeric materials with antimicrobial
activity include synthetic mimicry of antimicrobial polymers, antimicrobial peptides, and
more[14-16, 18]. Despite the fact that numerous efforts have been made in the development
of polymeric antimicrobial agents to kill or suppress the microbial grown to battle emerging
pathogenic diseases, but success against infectious diseases remains the same or little
improved[8, 9]. To combat resistant microorganisms, we have developed a new synthetic
approach to synthesize amidinourea containing liner antimicrobial polymer designated as
polyamidinourea (Figure 2.1). Amidinourea containing small molecules and their
derivatives have often been applied in medicinal chemistry[25, 26] and it also possesses
good antimalarial and fungicidal properties[27, 28]. Takeda Chemical Co., Japan, isolated
TAN-1057 (structurally related to amidinourea) from bacteria Flexibacter sp, which has
shown some potential antibacterial activities against methicillin-resistant Staphylococcus
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aureus[29]. However, the antimicrobial activity of amidinourea in polymer has not yet
been explored and no reports have been found on polyamidinourea.
Unlike the conventional antimicrobial polymers, polyamidinourea contain charges
in the backbone instead of the side chain (Figure 2.1). Polymers bearing charges on the
backbone have been reported maximum selectivity (HC50/MIC90) 20000 for S.
epidermidis[30]. Moreover, positive charge per every repeating unit, meaning constant
positive density, providing ample opportunities to modulate hydrophilicity and
hydrophobicity using a variety of primary and, or secondary amines. Also, having novel
antimicrobial polymers with unique functional groups will add to the functional group’s
diversity to make bacteria cells will find it hard to develop resistance.
Motivated by all the work done on antimicrobial polymers, we have developed a new
synthetic approach to synthesize amidinourea containing a liner polymer designated as
polyamidinourea. Here, we present a convenient synthetic technique to prepare a new class
of antimicrobial polymer. After careful study of the bacterial cell wall, cell membrane, and
cytoplasmic membrane, we have designed the amidinourea antimicrobial polymer with
hydrophobicity-hydrophilicity rightly balanced and sufficient charges on the surface. Two
series of polyamidinourea have been prepared using ethylenediamine (PE) and piperazine
(PP), and their biological assays have been determined evaluating minimum inhibitory
concentration (MIC), hemolysis assay (HC50), and membrane disruption mechanism study.
The PE series of polymers were inactive with lower selectivity with all the microbes tested.
The PP series of polymers exhibited quite impressive antimicrobial activities with higher
selectivity on M. smegmatis (WT), Shigella flexneri, S. aureus (MRSA), and S. auresus
(WT). Polymer PP-8K (PP series, Mn = 8000) showed a promising MIC value (13 μg/mL)
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with a selectivity of 30 against S. aureus (MRSA), supporting the concept that the novel
functional group has unique antimicrobial activity. Further study on the mechanism of
action revealed the bacterial cell membrane-disruption mechanism. To investigate the
effect of polymeric chain length on antimicrobial activity, we prepared and tested various
lengths polyamidinourea. In this research, we synthesized linear polyamidinourea, and we
will discuss their antimicrobial properties, hemolysis activity, and structure-functional
activity.
2.3. Result and Discussion
Research design. On the basis of the characteristics of the bacterial cell wall, outer
membrane, and cytoplasmic membrane, we designed the major part of the polymer as a
cationic hydrophilic-hydrophobic system, a target site for which the cytoplasmic
membrane was considered[19]. The aromatic hydrophobic nonpolar unit with the
amidinourea cationic charge polymeric structure provides surface-activity properties and
adsorption/absorption ability toward the bacterial cells[31]. The high lipophilicity caused
adequate damage of the structural system and principle of cell membranes, followed by
cell membrane disruption, leakage of cytoplasmic contents, and cell lysis[22, 32]. As
discussed earlier, the balance between hydrophobicity and hydrophilicity and the positively
charge play important roles in obtaining the desired antimicrobial properties. Hence, the
first task was to design an easy and modular synthetic pathway toward the amphiphilic
monomer and polymer. The amidinourea functional group has been proposed to make the
final antimicrobial polymer necessary to find a suitable synthetic approach toward the
making of amidinourea functional polymer (Figure 2.1). There are several methods
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available to make the synthesis amidinourea functional compound. The common methods
are hydrolysis of biguanides[27], reaction of guanidine with isocyanates[33], hydrolysis of
cyanoguanidines, reaction of Acyl-S-Methylisothiourea with amines[34], and reaction of
di-Boc-Guanidines with amines. As guanidinium has been used for making an amidinourea
functional compound and is a major source of positive charge, we have designed
guanidinum containing monomer to fulfil the synthetic target. The balance between
hydrophobicity and hydrophilicity is maintained by carefully introducing aromatic and the
alkyl chain, respectively. The iodo group is attached to the aromatic ring for further
incorporation of hydrophobic/antibacterial unit to make a more active polymer.
Monomer synthesis. The multiple-step approach was taken to obtain the monomer
A (scheme 2.1). Compound 1 was synthesized according to the literature and reacted with
commercially available N, N’-Di-Boc-1H pyrazole- 1 -carboxamide using dichloromethane
(DCM), acetonitrile (MeCN) and diisopropylethylamine (DIPEA) 7:3.5:1 ratio (v/v). After
extraction, the monomer was purified by column chromatography. The final product was a
white powder, and the overall yield was ~70%.
Polymer synthesis. To make a series of amidinoure-containing antimicrobial
polymers (PE & PP), monomer A reacted with ethylenediamine and piperazine,
respectively, in the presence of K2CO3 and tetrahydrofuran (THF) as a solvent. The
monomer ratio, temperature, and concentration of solvents played important roles in
achieving the targeted high molecular weight polymers. After screening several ratios,
temperatures, and solvent conditions, we found a 1:1.15 ratio of two monomers at 700C
and 2.60 mg/mL of solvent, as compared with monomer B, which provided high molecular
weight polymer with a good yield.
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Antimicrobial and hemolysis assay. The antimicrobial properties of synthesized
polymers, (i.e., their MIC90, value toward the growth of M. smegmatis (WT), Shigella
flexneri, S. aureus (MRSA), and S. aureus (WT) bacteria, and their HC50 toward red blood
cells were determined. The MIC90 and HC50 measurements were carried out by Ahmed and
Table 2.1. Characterization of antimicrobial polyamidinoureas by biological assay
MIC90 (μg/mL)a
Polymer

M.
smegmatis
(WT)

PP-14K

6.5

Shigella S. aureus
flexneri (MRSA)
25.5

25.5

Selectivityc
S.
aureus
(WT)
13

HC50
(μg/m
L)b

M.
smeg Shigella S. aureus
matis flexneri (MRSA)
(WT)

S.
aureus
(WT)

504

77.5

19.8

19.8

38.8

15.4

30.3

30.3

PP-8K

3.125-6.5

25.5

13

13

394

60.6126

PP-3K

102

>203

>203

>203

>2000

n.d

n.d

n.d

n.d

PE-11K

25

25-50

99

99

232

4.6-9

6

2.3

2.3

PE-7K

50-99

198

198

198

257

2.6-5

1.3

1.3

1.3

*Control

0.25-0.5

0.006

20

0.8-1.6

a

Inhibitory activity toward bacterial growth of M. smegmatis (WT), Shigella flexneri, S. aureus (MRSA)
and S. auresus (WT). (MIC90 = minimum inhibitory concentration preventing 90% bacterial growth), b
Hemolytic activity toward red blood cells (HC50 = concentration lysing 50% of blood cells), c ratio between
HC50/MIC90 value, * Ciprofloxacin was used as a control.

Wenjie in Dr. Tse Dinh lab as collaborators for this project. The biological data obtained
for these polymers are included in Table 2.1. The ratio of HC50/MIC90 was used to calculate
the selectivity. In summary, polymers with diamine series (PE-11K & PE-7K) were inactive
or showed little activity (Table 2.1), whereas polymers with the piperazine series (PP-14K
& PP-8K) showed better antimicrobial activities than the diamine series. More precisely, the
piperazine series showed promising antimicrobial activity on S. aureus (MRSA) compared
with using Ciprofloxacin as a control. Additionally, the antimicrobial activities toward the
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bacteria tested decreased as PE polymer length decreased, the opposite behavior observed
with the PP series of polymers.
These observations can be explained by taking different bacterial membranes into account.
The membranes of gram-negative bacteria like Shigella flexneri consist mostly of
phosphatidylethanolamine and anionically charged phosphatidyglycerol (PG), whereas
gram-positive bacteria like S. aureus and M. smegmatis have membranes that consist
mainly of anionically charged PG and cardiolipin[14, 35, 36]. Tew et al. reported that the
anionic surface charge, along with hydrophobicity, plays an important role in penetrating
the lipid bilayer of the bacterial cell membrane. If the synthesized polymers are attached
with highly positive charge and their amphilicity is rightly balanced, they will penetrate
the cell wall. Hence, less hydrophobic polymers PE were not able to penetrate the
hydrophobic core of the lipid bilayer and thus showed less activity on the tested microbe.
Hydrophilic polymers may prefer to remain in solution as opposed to being adsorbed to the
membrane. However, more hydrophobic polymers PP showed strong membrane activity.
These observations led to recognizing the maximum activity against S. aureus for PP-14K &
PP-8K polymers because it seemed to have the optimal amphilicity to penetrate the bacterial
membrane.
The better antimicrobial activity of a lower molecular weight polymer than of the
higher one can be addressed by again referring Tew’s work [14]. By analyzing different
lengths of oligomers while making antimicrobial peptides (AMPs), the Tew group proved
that a minimum chain length is necessary to obtain any antibacterial activity. In our work,
we observed that PP-8K showed better antimicrobial activity against S. aureus than PP-14K.
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Gram-positive bacteria like S. aureus have a 15-80 nm-thick, negatively charged murein
layer around the cell membrane. Complexation of a polyion with a lower charged species
is reversible, whereas oppositely charged polyion complexed irreversibly. Thus, assuming
that the negatively charged murein layer forms a polyion-polyion complex with the
positively charged PP-14K, increasing molecular weight (more charges on the polymer
surface) makes the dissociation of such a complex more difficult. Thus, the higher
molecular weight PP-14K gets stuck in the murein layer of gram-positive bacteria before
reaching the plasma membrane and thus shows less antimicrobial activity. To prove this
statement, we synthesized a low molecular weight polymer (PP-3K) and found inactivity on
all the microbes tested. Another rationalization can be considered for the higher activity of
PP-8K over all other polymers because of the lower size of PP-8K measured in the phosphate
buffer (Table 2.2). The nanoparticle sizes increased with PP-8K < PP-14K < PE-11K < PE-7K <
PP-3K, and antimicrobial activity decreased along with the size increase. This revelation
supports our earlier statement that a larger size of polymers might become stuck in the cell
wall and result in less or no antimicrobial activity on the cell membrane.
The HC50 values toward human red blood cells (RBCs) showed that the piperazine
series of polymers (PP) are less toxic than the ethylenediamine series of polymers (PE).
The maximum selectivity of 77.5 was achieved from the polymer PP-14K, whereas PP-8K
produced a range of 60.6-126. PP-3K polymer was nontoxic up to 2000 μg/mL. This
phenomenon can be explained by analyzing the difference between bacteria and the cell
membrane of RBCs. Bacterial membranes are more negatively charged than RBC
membranes. Red blood cells (RBCs) are composed of cholesterol and phosphatidylcholine,
whereas gram-negative bacteria such as E. coli contain mainly phosphatidylethanolamine
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and anionically charged phosphatidylglycerol, and gram-positive bacteria such as S. aureus
consist of anionically charged phosphatidyglycerol and cardiolipin. The higher positively
charged polymers can attract the RBCs’ membrane more strongly than the less charged
polymers. Thus, more positively charged PE polymers can lyse the RBCs more than less
positively charged PP polymers.
Polymer characterization. All Boc-protected polymers are soluble in regular
organic solvents like DCM and THF and exhibit high molecular weights and acceptable
experimental yields, as listed in Table 2.2. After Boc-deprotection polymer solubility was
reduced, polymers were soluble only in DMF and DMSO. The experimental yields were
low because of the removal of low-MW fragments during the polymer purification process
by precipitation. The proton NMR spectra of all polymers were consistent with their
predicted average structure. The analysis of predicted polymer structures examined the
ethoxy protons on the side chain of monomer A (b ~4.23 ppm) and the guanidinum amide
NH protons characteristic of monomer A (g ~ 12.20 ppm and f ~ 8.35 ppm, respectively).
As compared with monomer A, the resultant polymer showed only one Boc peak at 1.45
ppm, which is another confirmation of the final polymer structure. All proton peaks were
integrated relative to the ethylene oxide proton peak (b) and were in good agreement with
the integration values predicted by theoretical analysis. Figure 2.3 shows an example
spectrum of polymer PP.
2.4.

Conclusion
In this study, we investigated several important parameters that influence the

antimicrobial and hemolytic activity of polyamidinoureas. We demonstrated that polymer
length, charge, size, and ratio of hydrophobicity and hydrophilicity affect antimicrobial
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activity. We also demonstrated a noble synthetic approach to make linear antimicrobial
polyamidinourea with charges in the backbone. We discussed polymer condition
optimization and characterization by screening different solvents, temperatures, and ratios
of both monomers. Finally, we studied the antimicrobial assay along with HC50
determination. We identified that out of two types of polymers, the piperazine series of
polyamidinoureas were more active on bacterial cell membranes and less hemolytic on
RBCs than the diamine series of polyamidinourea.
2.5.

Outlook
Further study on the structure-function relationship along with the bacteria cell

membrane is needed to understand the actual antimicrobial mechanism. This research
might open a door for synthesis of antimicrobial polymer using the amidinourea functional
group in the backbone. Understanding bacterial cell walls and the membrane disruption
mechanism, a smart design in polymer structure might increase its antimicrobial activity
and selectivity. At the same time, proper balancing between hydrophobicity and
hydrophilicity needs to be considered while synthesizing antimicrobial polymers.
Incorporation of fluorescent material might enhance the live monitoring of antimicrobial
mechanism inside the bacteria cell membrane.
2.6.

Experimental Section
2.6.1. Monomer synthesis

A 100 mL round bottom flask (RBF) filled with compound 1 (1.00 g, 1.87 mmol)
(synthesized according to literature procedure[35]) and N,N’-Di-Boc-1H-pyrazole-1carboxamide (1.16 g, 3.73 mmol) under a nitrogen atmosphere. A mixture of acetonitrile
and DCM (1:2 v/v, 20.0 mL) was degassed with N2 flow for 10 min and transferred into
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the reaction flask via a cannula. The reaction mixture was allowed to stir at room
temperature overnight, and then was quenched with water before the two layers were
separated. The aqueous layer was extracted with DCM, and the combined organic layers
were washed with brine, filtered, and concentrated in vacuo. Column chromatography
under 30% of ethyl acetate in hexane yielded monomer A as a white powder (1.53 g, 80%
yield).
Scheme 2.1. Synthesis of guanidinum-containing aryl halide monomer A

1

H NMR (400 MHz, CDCl3, δ): 11.46 (s, 1H), 8.42 (t, J = 5.3 Hz. 1H), 7.35 (s, 1H), 4.09

(t, J = 4.4 Hz, 2H), 3.49 (t, J = 5.2 Hz, 2H), 1.43 (s, 9H), 1.39 (s, 9H). 13C NMR (400 MHz,
δ): 163.0, 155.4, 152.5, 152.0, 122.7, 86.8, 82.9, 78.1, 69.7, 68.6, 68.5, 28.0, 27.6. FT-IR
(neat): 3329, 2978, 2929, 2851, 1719, 1665, 1639, 1614, 1573, 1516, 1482, 1466, 1406,
1394, 1326, 1276, 1242, 1155, 1125, 1048, 1024 cm-1. HRMS (ESI+, m/z): [M + H+].
calcd. For C36H58I2N6O12, 1021.2275; found, 1021.2008.
2.6.2. Synthesis of polyamidinourea (PE and PP)
Boc PE: A Schlenk flask was charged with 20.0 mg (0.02 mmol) of Boc-protected
guanidine containing diiodo monomer A, 1.35 mg (0.02 mmol) of ethylenediamine, and
0.14 mg of potassium carbonate (0.001 mmol). Then 0.52 mL of anh THF solvent was
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added, and the Schlenk flask was degassed for 1 minute. The reaction was then stirred in a
pre-set oil bath at 70 0C for 16 hours under a nitrogen balloon. A viscous polymer solution
was filtered through a glass wool pipette to remove K2CO3. The polymer was purified by
re-precipitating in diethyl ether at first and then re-precipitating in methanol. The final
polymer was a white gel (12.9 mg with 65.5% yield).
Scheme 2.2. Synthesis of amidinourea polymer

Table 2.2. Properties of polyamidinourea PE and PP.
Polymer

R2

a

n

Mn
(g/mol)

b

PDI

Hydrodynamic
diameter, nmd

Yield

c

(%)

e

PE-11K

11

11200

1.9

146

65.5

PE-7K

7

7500

1.9

162

65

PP-14K

14

14500

1.4

76

62

PP-8K

8

8700

1.5

58

60

PP-3K

3

3100

2.5

225

65

a

Degree of polymerization. b Determined by gel permeation chromatography in THF. c PDI (polydispersity
index) = Mw/Mn. d Hydrodynamic diameter measured in PBS (2.5μM). e Percent yield per repeating unit
after repeated purification by precipitation.
1

H NMR (400 MHz, CDCl3, δ): 12.02 (s, 1H), 8.29 (s, 1H), 7.21 (s, 1H), 5.54 (s, 1H), 4.09

(t, 2H, J = 4.04), 3.86 (t, 2H, J = 3.79), 3.74 (t, 2H, J = 4.80), 3.55 (m, 2H), 3.31 (m, 2H),
36

1.44 (s, 9H). FT-IR (neat): 3405, 2531.9, 2159.37, 2033.8, 1662.4, 1437.4 cm-1. GPC: Mw
= 21400 g/mol, Mn = 11200 g/mol, PDI = 1.90

Figure 2.2. 1H NMR of Ethylenediamine polyamidinourea (PE).
Boc PP: A Schleck flask was charged with 20.0 mg (0.02 mmol) of Boc-protected
guanidine containing diiodo monomer A, 1.94 mg (0.02 mmol) of piperazine, and 0.14 mg
of potassium carbonate (0.001 mmol). Then 0.52 mL (by volume) anh THF solvent was
added, and the Schleck flask was degassed for 1 minute. The reaction was then stirred in a
pre-set oil bath at 70 0C for 16 hours under a nitrogen balloon. A viscous polymer solution
was filtered through a glass wool pipette to remove K2CO3. The polymer was purified by
re-precipitating in diethyl ether at first and then re-precipitating in methanol. The final
polymer was a white gel (12.5 mg with 62% yield).
1

H NMR (400 MHz, CDCl3, δ): 12.20 (s, 1H), 8.35 (t, 0.96H, J = 4.80), 7.22 (s, 1H), 4.10

(t, 2H, J = 4.55), 3.88 (t, 2H, J = 4.55), 3.80 (t, 2H, J = 5.05), 3.73 (br s, 2H), 3.61 (q, 2H,
J = 5.31, J = 5.05), 3.53 (br s, 2H), 1.44 (s, 9H). FT-IR (neat): 3280.07, 2938.13, 1668.25,
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1534.75, 1483.01, 1448.18, 1346.94 cm-1. GPC: Mw = 27500 g/mol, Mn = 14500, g/mol.
PDI = 140.

Figure 2.3. 1H NMR of Piperazine polyamidinourea (PP).
2.6.3. Boc deprotection of polyamidinourea
Scheme 2.3. Boc deprotection of polyamidinourea

General procedure for Boc deprotection of polyamidinourea
In a vial, Boc-protected polymer was dissolved in dicholoromethane (DCM) (1.00
mL) and trifluoroacetic acid (TFA) (1.00 mL) and stirred at r.t for 24 hours. Upon
precipitation in DCM, we confirmed that the complete Boc deprotection and solvent
evaporated in vacuo. Trifluoroacetic acid (TFA) was removed by azeotrope distillation and

38

the deprotected polymer purified by re-precipitating in ethyl acetate (EA) (2x). After drying
in a high vacuum, the Boc deprotection was confirmed by 1H NMR.
PE: Using the general procedure described above, the final deprotected polymer
was a white gel (62 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 10.56 (s, 1H), 9.11 (s, 1H), 8.52 (s, 2H), 7.65 (s, 1H),

7.36 (s, 1H), 4.11 (s, 2H), 3.79 (s, 2H), 3.70 (s, 2H), 3.20 (s, 2H). FT-IR (neat): 3360.36,
2160.37, 1736.79, 1681.18 cm-1

Figure 2.4. 1H NMR of Boc deprotected Ethylenediamine polyamidinourea (PE).
PP: Using the general procedure above the final deprotected polymer was a white
gel (66 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 10.41 (s, 1H), 9.13 (s, 1H), 8.61 (s, 1H), 7.38 (s, 1H),

4.11 (s, 2H), 3.80 (s, 2H), 3.71 (s, 2H), 3.53 (s, 4H), 3.50 (s, 2H), 3.38 (s, 2H) 7. FT-IR
(neat): 3360.36, 2160.37, 1736.79, 1681.18 cm-1
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Figure 2.5. 1H NMR of Boc deprotected Piperazine polyamidinourea (PP).
2.6.5. Antimicrobial assay
The compounds were dissolved in either DMSO or a buffer to make a stock
solution, which was then diluted into 96-well plates and diluted with a Muller Hinton (MH) medium to a constant volume. M. smegmatis (WT), Shigella flexneri, S. aureus
(MRSA), and S. aureus (WT) were taken from stock glycerol solutions, diluted into an MH medium, and grown overnight at 370C. Subsamples of these cultures were grown for 3
hours at 370C with agitation; the OD600 was measured, and then the cells were diluted to
0.001 OD600. The diluted cell solutions (approximately 105 cells/mL) were then added to
the 96-well plate. Table 2.1 shows the minimum concentration necessary to inhibit 50% of
the cell growth. We determined this by serial dilutions of the abiogenic polymer following
standard protocols. All reported values represent a minimum of quadruplicate experiments.
2.6.6. Hemolysis assay procedure
The hemolysis assay was carried out following the literature[36]. Basically, fresh
human RBCs purchased from Zenbio, Inc., were used without further processing. The
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RBCs were diluted for experimental use to 2% v/v RBCs in TBS and NaCl (TBS, pH 7.4,
0.01 M Tris-HCl, 0.155 M NaCl). The polymer samples were prepared as stock solutions
in dimethyl sulfoxide (DMSO) at 8 mg mL-1 and diluted with TBS to give a working
solution at 8000 µg mL-1. Serial dilutions were made in a 96-well plate (Bio-One, Cellstar,
Greiner) so that concentrations were stepwise halved eight times to give a range from 4,000
µg mL-1 to 31.25 µg mL-1 in 50 µL TBS. 10 µL of a 1 mg mL-1 stock solution of the
hemolytic compound triton X-100 was added to 40 µL TBS as a positive control, 50 µL
TBS as control (blank), and 100 µL TBS as background control. Finally, 50 µL of the 2%
RBC solution was added to each well containing a 50 µL sample or a control. The plate
was shaken gently for 1 minute then incubated for 1 hour at 37 °C. Thereafter, the plate
was centrifuged at 400 g for 5 minutes, subsequent to which 50 µL of the supernatant was
pipetted into a new 96-well plate, and the optical density (OD) was measured at 414 nm on
a UV-vis plate reader. For statistical analysis, blank OD414 values were subtracted from
both sample OD414 and positive control OD414 values. OD414 was normalized to 100 % with
the lowest OD414 assigned to 0% hemolysis, and the triton X-100 positive control assigned
to 100% hemolysis. The data were plotted as OD414 vs. log10 of the concentration using the
graphing software Graphpad Prism. A sigmoidal curve was fitted to the data by the
software to yield an HC50 value and 95% confidence intervals. The HC50 values reported
are the average values derived from three replicates of hemolysis experiments, and error
bars represent the standard error of the mean (SEM).
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CHAPTER III
SYNTHESIS OF POLYMERIC ANTIMICROBIALS TO OVERCOME
ANTIBIOTIC RESISTANCE AND INCREASE ANTIMICROBIAL EFFICACY
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3.1.

Abstract
Antimicrobial resistance is an increasingly serious threat to global public health

that requires an immediate global action. The bacterial resistance appears to be the result
of decreased outer membrane permeability and the development of the efflux mechanism
by resistant bacteria, which seems to be the commonest and most challenging. To overcome
antibiotic resistance associated with efflux pumping, we have developed polymeric
antimicrobials to increase local antimicrobial concentration at the bacterial cell membrane.
We synthesized a series of homo and di-block copolymeric antimicrobials using ringopening metathesis polymerization (ROMP), and we evaluated their antimicrobial efficacy
using various methods, including measuring the minimum inhibitory concentration (MIC).
Homo polymer was inactive, but the di-block copolymer exhibited some antimicrobial
activity against M. smegmatis (WT) (MIC = 2 μg/mL) and M.s/MtTOP (overexpression
strain) (MIC = 1 μg/mL). We have studied the effect of polymer chain lengths and block
ratios along with hydrophobicity on the polymer’s antimicrobial activity. Chapter 3 will
present the synthesis of homo and block copolymer via ROMP and the characterization
and effect of block ratio on antimicrobial activity.
3.2.

Introduction
Antimicrobial resistance is of immense concern in human health[1]. Antibiotic

resistance occurs when an antibiotic loses its capacity to inhibit bacterial growth. The
action of antibiotics like Ciprofloxacin (fluoroquinolones) is to inhibit the growth of
bacterial gyrase[1, 2]. Bacterial gyrase is an enzyme responsible for DNA replication,
repair, and recombination. The bacteria generate resistance to Cipro by development of the
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efflux mechanism[2]. In this resistance mechanism, antibiotics are pumped away before
reaching the cytoplasmic membrane.
Overcoming fluoroquinolone-type antibiotic resistance against the efflux
mechanism can be achieved by increasing the local concentration of drugs at the bacterial
cell membrane[3]. Because of the side effects, toxicity, and more important, chances of
killing the bacteria, it is not feasible to increase the number of dosages to increase the
antimicrobial concentration[4]. To increase local antimicrobial concentration to overcome
efflux resistance, we have come up with a polymeric approach in which Cipro-containing
monomer is attached with a positively charged hydrophobic monomer. We anticipated that
the positively charged hydrophobic units would enhance ionic interaction with the
negatively charged lipid bilayer in the bacterial cell membrane and thus increase the local
concentration of Cipro. In Chapter 2, we discussed and exhibited the value of polymeric
materials as an antimicrobial agent. We also demonstrated how antimicrobial polymers are
combatting pathogenic bacteria and showed improved efficacy.
The research goal is to synthesize a polymeric antimicrobial to overcome antibiotic
resistance associated with the efflux mechanism as well as to increase the antimicrobial
efficacy by increasing the local antimicrobial concentration at the cell membrane without
further dosing. We chose to employ Ciprofloxacin, a second-generation fluoroquinolone
antibiotic. Fluoroquinolones are a class of antibiotics used against a variety of infections
including urinary tract infections (UTIs), gastrointestinal infections, respiratory tract
infections (RTIs), and abdominal infections[1].
We synthesized a series of positively charged Cipro-containing antimicrobial homo
polymer and Cipro-TPP (triphenylphosphine)-containing hydrophobic antimicrobial di48

block copolymer using ROMP, which is a ruthenium catalyzed-based living
polymerization technique where the polymer chain length can be controlled[5, 6]. Charge
and hydrophobicity of the synthesized polymer were controlled by varying the TPP unit.
We tested the final polymers with resistant bacteria cell walls and determined their
antimicrobial properties, such as the minimum inhibitory concentration (MIC) value. The
Cipro-containing homo polymer was inactive against almost all the microbes tested, but
di-block copolymers exhibited some antimicrobial activity against M. smegmatis (WT)
(MIC = 2 μg/mL) and M.s/MtTOP (overexpression strain) (MIC = 1 μg/mL). In this
Chapter 3, we describe the synthesis of Cipro-containing homo and di-block copolymer
using ROMP along with its biological properties. We will also discuss the effect of block
ratio and hydrophobicity on antimicrobial activity.
3.3.

Result and Discussion
The antimicrobial must penetrate the bacterial cell wall in order to suppress the

bacterial cell growth[7]. It can enter the bacterial cell wall via a hydrophilic pathway
through the water-filled porin channels and by a hydrophobic pathway through the lipid bilayer [2-4, 8]. Carefully studying bacterial cell walls and cytoplasmic membranes, we have
designed and synthesized a rightly balanced hydrophobic-hydrophilic polymer.
Monomer synthesis: To use the ROMP method, we had to combine the Cipro with
norbornene. Norbornene and its derivatives are the most frequently used because of their
high ROMP activity and easy incorporation of substituents on the ring. The molecule
contains a cyclohexene ring with a double bond. The double bond carries the ring strain as
well as the reactivity of the norbornene. Scheme 3.1 shows the detailed reaction procedure
for the synthesis of the antibiotic-containing monomer. Commercially available
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oxonorbornene reacts with 2-(2-aminoethoxy)ethan-1-ol to prepare an alcohol form of
oxonorbornene. Hydroxyl derivatives of oxonorbornene are essential to make an ester
derivative with a carboxylic group presence in the Ciprofloxacin. The Boc-protected Cipro
directly reacts with the norbornene moiety via the Mitsunobu reaction to form the expected
drug monomer. To make more hydrophobic polymer, we prepared triphenylphosphine
(TPP) containing ROMP monomer. Three aromatic rings in TPP contribute
hydrophobicity, and TPP possesses some antimicrobial activity. Similar synthetic
procedure has been followed to achieve the final monomer.
Polymer synthesis: Ring opening metathesis polymerization (ROMP) is very
sensitive and must be done in an inert environment such as a nitrogen-charged glove box.
After following the general procedure, we repeatedly failed to polymerize the monomer
CIP-1 using ROMP. Several well-known procedures[4, 6] from different ROMP reaction
pathways were followed with modified conditions depending on structure. Although the
reaction was carefully carried out inside the glove box, at the end the polymer was not
obtained. Later, we changed reaction conditions to induce the polymer’s formation.
Following the literature, different solvent conditions with catalyst loading were tried (Table
3.1); however, nothing worked to form the living ROMP polymer. The following table
shows the different reaction conditions tried to polymerize the antibiotic monomer. We
chose the percentage of solvent and catalyst from the literature, most of which suggested
Grubbs’ third-generation catalyst for its reactivity and stability[5, 6, 9]. However, repeating
the process using the Grubbs’ catalyst yielded the same result. Later, we believed that the
amine could have interacted negatively with the Grubbs’ catalyst’s ruthenium center.
However, other literature showed that Boc-protected amine does not interact with the
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Grubbs’ catalyst’s center. Monomer CIP-1 structure is also Boc protected and NMR
confirmed.
At this point, we were not able to find any rational data to explain the failure of the
ROMP process. Later, we changed the structure of the antibiotic monomer to make it work.
At first we thought the hydrophilic ethoxy alkyl chain might interact with Grubbs’ catalyst
[6]. Then we made a new antibiotic monomer by changing the hydrophilic ethoxy alkyl
chain to a more hydrophobic alkyl chain (CIP-2). Schemes 3.2 and 3.3 show the modified
antibiotic monomer structure, which was confirmed by 1H-NMR,

13

C-NMR, and IR.

Unfortunately, repeating the ROMP polymerization process using Grubbs’ second- and
third-generation catalyst did not result in polymerization.
Unfortunately, after repeating every condition under which ROMP was conducted
with the previous antibiotic monomer, this monomer also failed to polymerize.
Later, we changed the alkyl length of antibiotic monomer to reduce any interaction
between the monomer chain and the ruthenium center of Grubbs’ catalyst. Because this
was the only option we could change, we decided to make a short-chain antibiotic monomer
(CIP-3) to avoid any negative effect by the alkyl chain. The ROMP had a result similar to
that from earlier antibiotic monomers. We tried all the possible conditions including
changing solvent and catalyst ratio. We did the reaction in a Schlenk flask at 400C to 500C
to see whether temperature could have any influence on polymerization. However, the
process failed under all conditions.
With the failure of all previous trials, we changed the polymerization technique. At
first, we tried to polymerize the precursor of the CIP-1 monomer via ROMP and then add
Cipro by the post-polymerization method. The first attempt to polymerize the bromine
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Table 3.1. List of different solvent and catalyst condition tried for ROMP

a

No.

% catalysta

% DCMb

% Methanol

% THFc

GPCd

1.

2

100

0

0

1402

2.

1.5

100

0

0

1307

3.

1

100

0

0

1536

4.

1-2

90

10

0

1465

5.

2.5

80

20

0

1203

6.

1.5-2.5

50

0

50

1005

7.

2

50

10

40

1103

Grubb’s third-generation catalyst, b dichloromethane, c tetrahydrofuran, d gel permeation chromatography

containing ROMP failed as a result of solubility issue. Finally, we were successful with the
polymerization of tosyl containing ROMP was successful and attached Cipro later. Later,
we synthesized block copolymers following the same technique and using
triphenylphosphine (TPP) containing ROMP monomer.
Antimicrobial assay: Antimicrobial study on synthesized Cipro containing homo
and di block copolymers has been carried out by Dr. Arasu Annamalai in Dr. Tse Dinh lab
as a collaborator for this project and used on several resistant bacterial cell membranes.
Table 3.2 shows the minimum inhibitory concentration result. On the basis of the data,
Cipro homo polymer was inactive with almost all microbes tested, but Cipro-TPP di-block
copolymers (1:1.3 ratio) exhibited some antimicrobial activities. The inactivity of the Cipro
homo polymer can be explained by saying that the positive charge is not enough to increase
the local concentration of Cipro. Thus, the CIP homo polymer failed to reach the
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cytoplasmic membrane and lost its activity. Hydrophobicity is another essential parameter
to enhance the bacterial membrane penetration. Thus, the more hydrophobic polymer CIPTPP block copolymer possesses some antimicrobial properties (Table 3.2). The maximum
antimicrobial activity recorded on M.s/MtTOP (overexpression strain) (1 μg/mL) by the diblock copolymer (CIP-TPP). To support this statement, we increased the TPP ratio and
synthesized more hydrophobic CIP-TPP di-bloc copolymer (1:2 ratio). Unfortunately, this
combination did not show any activity against the microbes tested. On the basis of this
result, we concluded that there must be an optimum ratio between hydrophobicity and
hydrophilicity for better antimicrobial activity. Furthermore, slow kinetics could be another
potential issue for inactivity or poor antimicrobial properties of synthesized polymers.
Table 3.2. Minimum inhibitory concentration (MIC) assay
Compounds (μg/mL)a

MIC
Strains

Cipro
(control)

CIP homopolymer

CIP:TPP =
1: 1.3b

CIP:TPP
= 1:2b

M. smegmatis (WT)

0.25

>4.7

2

No
activity

M.s/MtTOP(overexpression)

0.25

>2.3

1

M.s/pknol

0.25

>2.3

1

E. coli (WT)

0.03

>14

24.75

a

inhibitory activity towards bacterial growth of M. smegmatis (WT), M.s/MtTOP (overexpression),
M.s/pknol (control vector) and E. coli (WT) (MIC90 = minimum inhibitory concentration preventing 90%
bacterial growth), b bl-ock co-polymer

3.4.

Conclusion
We have demonstrated the synthesis of Cipro-containing homo and di-block

copolymers

using ROMP. We also

discussed polymerization condition

and

characterization. Finally, we did antimicrobial assay determining MIC. The MIC values
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were showed poor or no activity against the resistant bacteria tested. By analyzing the
result, we concluded that a proper balance between hydrophobicity-hydrophilicity along
with positive charge might be missing from the polymers we prepared. Another conclusion
can be drawn from the inactivity of polymers because of poor pharmacokinetics or slow
release to the bacterial membrane. Further study needed to address those problems and to
increase the antimicrobial activity of the synthesized polymers.
3.5.

Outlook
The goal of this research was to increase local concentration of antimicrobial agents

at the bacterial cell wall. We incorporated Cipro and Cipro with triphenylphosphine via
ROMP. The Chapter 3 mainly discusses our synthetic approach along with characterization
of the monomer, homo, and di block copolymers. Further study was needed to complete
this project, including a deep understanding of the bacterial cell wall, cytoplasmic
membrane, and outer membrane. We concluded that hydrolysis kinetics might provide the
reason behind the inactivity of the polymers by analyzing the release process inside the
bacterial cell wall.
3.6. Experimental Section
3.6.1. Monomer synthesis
Scheme 3.1. Synthesis of Cipro containing ROMP monomer (CIP-1)

Compound 3a was synthesized according to the literature[10]. More precisely, in a reaction
flask, Ciprofloxacin (1.00 g, 3.02 mmol) was dissolved in water. In another flask, di-butyl
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dicarbonate (Boc) (0.70 g, 3.17 mmol) was dissolved in tetrahydrofuran (THF) and added
to the reaction flask drop by drop using an addition funnel. The reaction mixture was stirred
at r.t. overnight. The solvent was then removed in vacuo, and Boc-protected Cipro was
dissolved in DCM. The mixture of product was washed with water (3x) and brine (1x). The
final white powder product was dried in a high vacuum (0.85 g, 90% yield).
CIP-1: Compound 3a (2.00 g, 4.63 mmol) and 3h (2.50 g, 8.11 mmol) and K2CO3 (1.90 g,
13.9 mmol) were added into a round-bottom flask (RBF). The solvent DMF was added to
the RBF, and the reaction mixture was stirred at 600C overnight. The next day, the reaction
mixture was quenched in water, and precipitate was collected through vacuum filtration.
The final product (precipitate) was dissolved in DCM and washed with water (3x) and
brine (1x). After column purification with a 30% EA-Hexane mixture, the final white
amorphous product was dried over a high vacuum (2.31 g and 75 % yield).
1

H NMR (400 MHz, CDCl3, δ): 8.54 (s, 1H), 8.05 (d, J = 13.1 Hz. 1H), 7.29 (s, 1H), 6.49

(s, 2H), 5.25 (s, 2H), 4.41 (t, J = 5.1 Hz, 2H), 3.78 (t, J = 4.8 Hz, 2H), 3.71 (s, 4H), 3.67 (t,
J = 5.1 Hz, 4H), 3.42 (m, 1H), 3.22 (t, J = 4.8 Hz, 4H), 2.90 (s, 2H), 1.51 (s, 9H), 1.33 (d,
J = 6.8 Hz, 2H), 1.17 (m, 2H). 13C NMR (400 MHz, δ): 176.4, 173.1, 165.3, 154.7, 152.2,
148.4, 144.6, 144.5, 138.1, 136.6, 123.4, 123.3, 113.6, 113.4, 110.2, 105.1, 80.9, 80.3, 68.8,
67.2, 63.7, 47.3, 38.3, 34.6, 28.5. FT-IR (neat): 3690.8, 3501.3, 2976.2, 2920.7, 2861.6,
1692.0, 1619.6, 1478.8, 1393.5, 1244.2, 1163.1, 1124.7, 1022.3 cm-1.
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Figure 3.1. 1H NMR of CIP-1
Scheme 3.2. Synthesis of Cipro containing hydrophobic ROMP monomer (CIP-2)

Compound 3b was synthesized according to the literature[11]. Basically, furan (2.00 g,
29.4 mmol) and 1H-pyrrole-2,5-dione (2.71 g, 27.9 mmol) were dissolved in ethyl acetate
and stirred at 900C overnight. The resulting precipitates were collected by vacuum filtration
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and washed with water (3x). The final product was white powder and was dried over high
vacuum (4.10 g and 85% yield).
Compound 3c was synthesized according to the literature procedure[12]. More precisely,
compound 3a (2.00 g, 4.63 mmol), 1,6-dibromohexane (1.13 g, 4.63 mmol), and K2CO3
(3.2 g, 23.1 mmol) were dissolved in DMF and stirred at 500C overnight. The final white
powder product was collected after extraction (DCM, water, and brine) and column
purification (30% EA in hexane) (1.54 g and 56% yield).
CIP-2: Monomer CIP-2 was prepared following the same procedure as CIP-1. Basically,
compound 3c (1.20 g, 2.01 mmol), compound 3b (0.36 g, 2.22 mmol), and K2CO3 (1.38 g,
10.0 mmol) were dissolved in DMF and stirred at 600C overnight. The final white powder
product was collected after extraction and column purification (0.80 g and 53% yield).
1

H NMR (400 MHz, CDCl3, δ): 8.52 (s, 1H), 8.05 (d, J = 13.1 Hz. 1H), 7.29 (s, 1H), 6.51

(s, 2H), 5.26 (s, 2H), 4.29 (t, J = 6.5 Hz, 2H), 3.65 (t, J = 4.5 Hz, 2H), 3.49-3.44 (m, 3H),
3.22 (t, J = 5.0 Hz, 4H), 2.83 (s, 2H), 1.78-1.73 (m, 4H), 1.59 (m, 2H), 1.50 (s, 9H), 1.481.44 (m, 2H), 1.33 (m, 4H), 1.17 (m, 2H).

13

C NMR (400 MHz, δ): 176.4, 165.9, 154.7,

148.2, 136.6, 81.0, 80.3, 64.9, 47.5, 38.9, 34.6, 28.7, 28.5, 27.6, 26.4, 25.6. FT-IR (neat):
3615.1, 3516.2, 2973.3, 2934.4, 2863.6, 2827.3, 1699.1, 1682.7, 1610.6, 1503.5, 1474.5,
1426.2, 1400.5, 1333.8, 1247.9, 1211.5, 1167.9, 1127.4, 1080.6 cm-1.
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Figure 3.2. 1H NMR of CIP-2.
Compound 3d was synthesized following the same procedure as compound 3c. Basically,
compound 3a (2.00 g, 4.63 mmol), 1,2-dibromoethane (0.86 g, 4.63 mmol), and K2CO3
(3.20 g, 23.1 mmol) were dissolved in DMF and stirred at 500C overnight. The final white
powder product was collected after extraction and column purification (1.20 g and 50%
yield).
CIP-3: Monomer CIP-3 was prepared following the same procedure as CIP-1. Basically,
compound 3d (2.00 g, 3.71 mmol), compound 3b (0.67 g, 4.10 mmol), and K2CO3 (2.60
g, 18.5 mmol) were dissolved in DMF and stirred at 600C overnight. The final white
powder product was collected after extraction and column purification (1.20 g and 56%
yield).

58

Scheme 3.3. Synthesis of Cipro containing short chain ROMP monomer (CIP-3)

1

H NMR (400 MHz, CDCl3, δ): 8.49 (s, 1H), 7.98 (d, J = 7.9 Hz. 1H), 7.28 (s, 1H), 6.51

(s, 2H), 5.26 (s, 2H), 4.43 (t, J = 5.0 Hz, 2H), 3.87 (t, J = 5.3 Hz, 2H), 3.65, 3.65 (t, J = 4.5
Hz, 4H), 3.43 (m, 1H), 2.95 (s, 2H), 1.50 (s, 9H), 1.33 (d, J = 6.6 Hz, 2H), 1.19 (m, 2H).
C NMR (400 MHz, δ): 176.2, 164.5, 154.6, 148.4, 144.4, 138.0, 136.5, 113.5, 105.1,

13

80.8, 80.2, 80.9, 47.6, 37.8, 34.6, 28.4. FT-IR (neat): 3090.8, 3001.3, 2890.6, 2851.3,
1768.7, 1731.2, 1698.1, 1621.9, 1501.5, 1430.5, 1399.5, 1341.7, 1240.7, 1155.8. cm-1.

Figure 3.3. 1H NMR of CIP-3
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Scheme 3.4. Synthesis of tosyl containing ROMP monomer (3e)

Compound 3e was synthesized according to the literature[13]. Basically, in an RBF,
compound 1 (5.20 g, 20.5 mmol) (Scheme 3.5) and triethylamine (4.18 g, 41.0 mmol) were
dissolved in DCM and made a homogenous solution by stirring at r.t. Later, the reaction
mixture was cooled to 00C using an ice bath. Tosylchloride (4.30 g, 22.5 mmol) was
dissolved in DCM and added to the reaction mixture using an addition funnel over an hour.
The RBF was left overnight stirred at 400C. The product was extracted in ethyl acetate and
washed with water (3x) and brine (1x). The final white crystalline product was purified by
recrystallization in a THF and diethyl ether mixture (7.00 g, 84% yield).
1

H NMR (400 MHz, CDCl3, 25 0C): δh = 7.78 (d, J = 4.06, 2H), 7.30 (d, J = 4.20, 2H), 6.50

(s, 2H), 5.28 (s, 2H), 4.23 (t, J = 4.05, 2H), 3.64-3.55 (m, 6H), 2.90 (s, 2H), 2.50 (s, 3H).

Figure 3.4. 1H NMR of monomer 3e
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Scheme 3.5. Synthetic route to TPP containing monomer 3g

Compound 3g was synthesized according to the literature[10]. A pressure tube was charged
with 2-(2-(2-bromoethoxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-1,3 (2H)dione (1.33 g, 0.004 mol) and triphenylphosphine (4.41 g, 0.016 mol). A minimum amount
of acetone as a solvent was added to the pressure tube to cover both reactants. The reaction
vessel was then closed and made airtight using Teflon paper. The reaction vessel was
heated at 500C for 24 hours. The reaction progress was monitored and confirmed by thin
layer chromatography (TLC). The colorless solution was cooled to room temperature, and
the viscous reaction mixture was dissolved in a minimum amount of DCM to make a
homogenous

solution.

Upon

precipitation

in

ethyl

acetate

(EA),

unreacted

triphenylphosphine was removed by vacuum filtration. The precipitate was washed with
EA and dried over high vacuum overnight. An amorphous crystalline final product (0.50g
and 20% yield) was confirmed by 1H NMR.
1

H NMR (400 MHz, CDCl3, 25 0C): δh = 7.78-7.68 (m, 15H), 6.5 (s, 2H), 5.21 (s, 2H), 4.2

(p, J = 5.56 Hz, 2H), 3.92-3.86 (dt, J = 5.8 Hz, J = 5.5 Hz, 2H), 3.35 (t, J = 5.8 Hz, 2H),
3.25 (t, J = 5.5 Hz, 2H), 2.89 (s, 2H). 13C NMR (400 MHz, δ): 176.0, 136.5, 134.8, 134.7,
134.0, 133.9, 130.2, 130.1, 119.3, 118.4, 80.9, 67.2, 64.2, 64.1, 47.5, 38.0. FT-IR (neat):
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3605.6, 3036.9, 2956.2, 2876.8, 2854.4, 2786.1, 1769.5, 1730.1, 1694.5, 1481.7, 1436.2,
1402.7, 1336.4, 1126.3, 1110.7, 1021.9.
Scheme 3.6. Synthetic route toward precursor compound 3h

Compound 1 was synthesized according to the literature[10]. An RBF was charged with
exo-3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride (5.00 g, 30.0 mmol) and dissolved in
50.0 mL methanol. The reaction mixture was cooled to 00C using ice bath with stirring. 2(2-aminoethoxy)ethanol (7.50 g, 71.0 mmol) was dissolved in methanol and added into the
RBF drop by drop using an additional funnel. The RBF was stirred at 600C overnight. The
reaction progress was confirmed by TLC, and methanol was removed by rotary evaporator.
The colorless, oily liquid was dissolved in ethyl acetate and washed with water (3x) and
brine (1x). Ethyl acetate was evaporated, and the liquid product was dried in a high vacuum
overnight (5.69 g and 75% yield).
1

H NMR (400 MHz, CDCl3, 25 0C): δh = 6.52 (s, 2H), 5.28 (s, 2H), 3.67 (t, J = 4.05, 2H),

3.64-3.60 (dt, J = 5.05, 4H), 3.59 (t, J = 4.07, 2H), 2.88 (s, 2H), 2.50 (br s, 1H)
Compound 3h was synthesized according to the literature[10]. An RBF was filled with 2(2-(2-hydroxyethoxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione
(8.00 g, 31.6 mmol) and triphenylphosphine (9.12 g, 34.7 mmol) and dissolved in DCM.
The RBF was stirred at r.t. to make a homogeneous solution. In another flask, carbon
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tetrabromide (11.5 g, 34.7 mmol) was dissolved in DCM and added to the RBF drop by
drop using an additional funnel. The overall reaction mixture was stirred at r.t. for 1 hour,
and reaction progress was monitored by TLC. The pure product was obtained by column
chromatography (Hx/EA: 8.5/1.5) without further purification. The colorless, viscous
product was confirmed by 1H NMR (5.50 g and 55% yield.
1

H NMR (400 MHz, CDCl3, 25 0C): δh = 6.44 (s, 2H), 5.18 (s, 2H), 4.02 (t, J = 4.1, 2H),

3.67-3.58 (dt, J = 5.06, 4H), 3.33 (t, J = 4.2, 2H), 2.80 (s, 2H).
3.6.2. Synthesis of Cipro-containing antimicrobial polymer via ROMP
Polymer 3f, tosyl-containing intermediate polymer (3f) was synthesized according
to the literature[13]. Basically, monomer 3e (50.0 mg, 0.21 mmol) was charged into a glass
vial and put into a nitrogen-charged glove box. The monomer was dissolved in 1.00 mL
DCM and stirred to make a clear solution. The DCM was prepared by three freeze-thaw
cycles before the reaction occurred. Grubb's third-generation catalyst (1.80 mg, 0.0021
mmol) (1 mmol%) was prepared by dissolving in DCM. The freshly dissolved Grubb's
third-generation catalyst was added to the monomer containing a vial in one pot and stirred
at r.t. for 1 hour.
Scheme 3.7. Synthesis of Cipro containing homo polymer (CIP poly)
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After 1 hour, the reaction mixture was quenched by ethyl vinyl ether. The product was
obtained by reprecipitation in ethyl acetate (2x) and diethyl ether (1x) and was dried over
a high vacuum. A white fiber-like product was confirmed by 1H NMR (30.1 mg and yield
65%). 1H NMR (400 MHz), CDCl3, δ: 7.82-7.76 (m, 2H), 7.42-7.30 (m, 2H), 6.03 (s, 1H),
5.75 (s, 1H), 5.00 (br s, 1H), 4.42 (br s, 1H), 4.13 (s, 2H), 3.62-3.55 (m, 3H), 3.48-3.35 (m,
2H), 2.5 (s, 3H).
CIP poly: The final Cipro-containing ROMP polymer was synthesized using the postpolymerization technique. The synthetic procedure was the same as for the synthesis of
CIP-1 monomer (Scheme 3.1). More precisely, in a 50 mL RBF, polymer 3f (55.6 mg,
0.15 mmol), compound 3a (83.5 mg, 0.19 mmol), and K2CO3 (107 mg, 0.77 mmol) were
dissolved in acetone and stirred at 600C overnight. The reaction mixture was filtered
through a glass wool pipette to remove K2CO3, and the solvent was dried off in vacuo. The
resulting polymer was dissolved in DCM and purified by reprecipitating in diethyl ether
(3x). The white fiber-like gel final product was dried in a high vacuum (107 mg, 72%
yield).
1

H NMR (400 MHz), CDCl3, δ: 8.34 (s, 1H), 7.05 (s, 1H), 7.10 (s, 1H), 6.00 (s, 1H), 5.71

(s, 1H), 4.98 (s, 1H), 4.43-4.33 (m, 3H), 3.76-3.33 (m, 10H), 3.43-3.36 (m, 3H), 3.18 (s,
4H), 1.48 (s, 9H), 1.27 (s, 2H), 1.16 (s, 2H). FT-IR (neat): 3525.1, 3432.2, 3020.2, 2937.6,
1720.1, 1698.3, 1403.5, 1364.2, 1356.4, 1236.9, 1182.5 cm-1.
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Figure 3.5. 1H NMR of CIP homo polymer
Scheme 3.8. Synthesis of di block copolymer (CIP-TPP block co-poly)

CIP-TPP block copolymer: The block copolymer was synthesized following the same
procedure as CIP poly synthesis (Scheme 3.7). At first, monomer 3g was polymerized
using the ROMP procedure, and later monomer 3f was added to the reaction mixture to
make a di-block copolymer of 3(g-f). The post-polymerization of intermediate polymer,
3(g-f) to CIP-TPP block copolymer was achieved following the same procedure as
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discussed in Scheme 3.7. More precisely, compound 3g (20.0 mg, 0.03 mmol), compound
3f (12.2 mg, 0.03 mmol), and Grubb’s third-generation catalyst (0.02 mg, 1 mole%)
produced a white fiber-like product (22.0 mg, 68% yield).

Figure 3.6. 1H NMR of CIP-TPP block copolymer
The post-polymerization was carried out by addition of compound 3a (51.6 mg, 0.12
mmol), intermediate di-block copolymer 3(g-f) (107 mg, 0.10 mmol), and K2CO3 (66.0
mg, 0.48 mmol) in the presence of acetone as a solvent. The white fiber-like final product
was purified by reprecipitating in diethyl ether and ethyl acetate, respectively. The final
product was dried in a high vacuum (76.7 mg and 68% yield).
1H NMR (400 MHz), CDCl3, δ: 8.34 (s, 1H), 7.76 9-7.68 (br m, 20H), 7.20 (s, 1H), 5.99
(br s, 2H), 5.70 (m, 2H), 4.95 (br s, 2H), 4.40-4.33 (m, 4H), 4.11 (br s, 2H), 4.10-3.61 (m,
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16H), 3.43-3.32 (m, 10H), 3.17 (s, 4H), 1.48 (s, 9H), 1.29 (s, 2H), 1.15 (s, 2H). FT-IR
(neat): 3682.7, 3601.0, 3499.3, 2936.2, 2912.7, 2866.3, 2831.4, 2756.1, 1780.4, 1742.5,
1594.3, 1592.4, 1468.3, 1382.5, 1253.3, 1211.4, 1136.3, 1122.8, 1056.3 cm-1.
3.6.3. Polymer characterization and block ratio calculation
As mentioned earlier, direct polymerization of CIP-1 failed, and Cipro was
attached after the post-polymerization reaction. The structure of the final polymer was
determined by thorough analysis of 1H-NMR. A comparative NMR is presented in Figure

Figure 3.7. 1H NMR comparison of Tosyl and CIP homo polymer.
3.7 for representation. The NMR showed the disappearance of methyl peaks from polymer
3f (peak j) at 2.5 ppm and the appearance of characteristic peaks from Boc-protected Cipro
(k, l). Another confirmation of Cipro attachment after the post-polymerization reaction can
be considered as the disappearance of tosyl-aromatic peaks from compound 3f at 7.7~7.27
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ppm and the appearance of Cipro aromatic peaks at 8.4 ppm (h) and 7.6 ppm (i). The block
ratio between two monomers (Cipro and TPP) was calculated using final 1H NMR spectra
(Figure 3.7). The Boc group was considered as 9 protons and triphenylphosphine as 15
protons. The ratio between these two protons was reported as the block ratio of CIP-TPP
di-block copolymer.
3.6.4 Boc deprotection of antimicrobial polymers
Scheme 3.9. Boc deprotection of Cipro homo polymer (CIP poly)

The Boc deprotection of synthesized polymers was carried out by following the literature.
Basically, Boc-protected polymer and trifluoroacetic acid (TFA) (1:5 equivalent by
volume) were dissolved in DCM and stirred at r.t. overnight. The solvent was distilled off
in vacuo, and the resultant polymer was dissolved in DMF. Upon being reprecipitated in
diethyl ether (2x) and ethyl acetate (1x), a white fiber-like deprotected final polymer was
dried in a high vacuum.
Boc deprotection of CIP homo polymer: following the general procedure discussed
above, the final deprotected polymer was a white fiber (72% yield).
1

H NMR (400 MHz), DMSO-d6, δ: 9.20 (br s, 2H), 8.31 (s, 1H), 7.56-7.35 (m, 2H),

5.85-5.66 (m, 2H), 4.83 (br s, 1H), 4.21 (br s, 3H), 3.66-3.33 (m, 10H), 1.20 (s, 2H),
1.08 (s, 2H). FT-IR (neat): 3613.2, 3540.4, 3033.2, 2954.8, 1740.3, 1654.9, 1432.2,
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1368.4, 1254.7, 1136.1 cm-1.

Figure 3.8. 1H NMR of Boc deprotected CIP homo polymer.
Boc deprotection of CIP-TPP di-block copolymer: following the general
procedure discussed above, the final deprotected polymer was a white fiber (68% yield).
1

H NMR (400 MHz), DMSO-d6, δ: 9.4 br s, 1H), 8.34 (m, 1H), 7.93-7.36 (m, 10H), 7.44-

7.34 (m, 2H), 5.99-5.69 (m, 4H), 4.83 (br s, 2H), 4.33-4.23 (m, 4H), 3.92 (br s, 2H), 3.533.32 (m, 14H),1.25 (s, 2H), 1.08 (s, 2H). FT-IR (neat): 3517.3, 3412.5, 3235.2, 2948.2,
2936.7, 2799.2, 2785.4, 1754.3, 16.92.5, 1543.4, 1479.5, 1441.8, 13.85.6, 1326.5, 1211.3,
1056.3 cm-1.
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Figure 3.9. 1H NMR of Boc deprotected CIP-TPP di-block copolymer polymer.
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CHAPTER IV
FUNCTIONAL GROUP MODULATED CONJUGATED POLYMER FOR
CELLULAR IMAGING AND GENE DELIVERY
Manuscript is in progress
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4.1.

Abstract
Cellular entry pathways depend on the surface charge and physical properties of

external materials. A rigid aromatic backbone structure and positively charged side chain
make guanidine-containing conjugated polymers (CPs) best suited as the delivery vehicle.
Guanidine-containing CPs are excellent gene carriers because of their intrinsic fluorescent
and surface charge properties. A small modification of guanine-containing CPs could lead
to the inactivation of the polymer or a change in its biological properties. Interestingly,
modification of the guanidine group with amines and alcohols showed impressive cellpenetrating properties, and that makes these polymers suitable for carrying external agents
through the cell membranes. Modification of guanidine moiety in CPs with more
hydrophobic and/or hydrophilic compounds led us to overcome the solubility issue along
with the change in physical properties essential for cellular imaging and gene delivery. In
this research, a series of guanidine-modified CPs was prepared and their transfection
efficiency through the cell membranes has been evaluated using various methods,
including confocal imaging. Modulated polymers were then tested as a gene delivery agent,
and a 20% siRNA knockdown was achieved in normal human bronchial epithelial (NHBE)
cells without causing cytotoxicity. The NHBE (known as primary) cells are difficult to
transfect and the gold-standard transporter lipofectamine was toxic for this cell line. In this
Chapter, we discuss details of the modification chemistry, modification-dependent cellular
behaviors, and a knockdown of a target protein in primary cells.
4.2.

Introduction
CPs are macromolecules with highly delocalized π-conjugated backbones and

amphiphilic side chains[1-3]. CPs have been widely used for specific biological
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applications because of their unique properties such as large absorption extinction
coefficients, amplified quenching, high quantum yields, and tunable absorption and
emission maxima[3, 4]. Incorporation of guanidine moiety as a side chain of CPs has
attracted attention in numerous biological applications due to the valuable hydrogen
bond-based catalysts[5]. Guanidinum is a part of the side chain of arginine and remains
charged over a wide pH range, which is reflected in the high pKa value (12.48) of its
protonated counterpart[6]. There are many guanidine-containing peptides available
because of their ease of modification and straight-forward synthetic strategy.
Guanidinum groups have proven to be a valuable addition to polymers, not only because
of their cationic properties, but also for their mimic of cell-penetrating peptides
(CPPs)[7], molecular recognition[8], and antimicrobial agent[9].
The chemical modification of the guanidine group is often considered to destroy
its functionality. Nitrogen atoms of Boc-guanidine bearing electron-withdrawing
substituents act as a reactive nucleophile[10]. The fairly acidic N-H protons in Bocguanidine can be further functionalized with a variety of electrophiles to make diverse
functional material[11]. There have only been a few methods reported so far for
guanidine modification, including the reaction between guanidine with alcohols under
the Mitsunobu reaction condition[12] and alkylation of guanidine with electrophiles such
as alkyl halides under basic conditions[10]. Recently Kessler et al.[11] modified the
guanidine group of Cilengitide ligand with N-methylation, N-alkylation, and N-acylation
and successfully demonstrated the increased selectivity of Cilengitide ligands. Takemoto
et al.[12] reported a convenient and direct modification of guanidine using a palladiumor iridium-catalyst. Moreover, in Chapter 2, we presented a synthesis of unique
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antimicrobial polyamidinourea using guanidine modification chemistry. The direct
modification of the guanidine head group has received much less attention, and we found
no report on modification of guanidine moiety in polymers.
Despite the importance of guanidinum moiety in biological applications, it has
some limitations in terms of its use in cellular imaging and gene or drug delivery. More
precisely, guanidine-containing CPs have limited solubility in organic solvents. We
hypothesized that modification of guanidinum moiety with more hydrophobic and/or
hydrophilic compounds in CPs might improve the solubility and enhance the physical
properties. Hence, we studied guanidine modification chemistry and developed a direct
method for the guanidine head group modification in CPs. We anticipated that replacing
the amino substituent with the strongly basic components would affect the physical
properties and, in particular, the ionization and charge distribution. We also anticipated
that changing physical properties, ionization, and charge distribution would enhance
cellular transfection and imaging and reduce cytotoxicity, which is essential for gene
delivery. We have followed the catalyst-free post-polymerization technique to
incorporate a variety of hydrophilic and the hydrophobic functional group in guanidinecontaining CPs. The modification reaction proceeds via generation of isocyanate in situ
reaction conditions. With this technique, we have shown that a structural diverse polymer
can be synthesized without observing tedious polymerization steps. To test the
hypothesis, we first modified the guanidine head group with diisopropylamine (DIPA),
and a dramatic change in solubility as well as physical properties of DIPA-modified CP
were observed. Later we broadened our synthetic scheme to further head group
modification with various functional compounds. We incorporated more hydrophobic
75

and hydrophilic groups such as piperidine, morpholine and aminoethoxyethanol and
determined their physical and photo physical properties. The modulated CPs were able
to integrate via 1H NMR without any difficulty, and overall yields were high.
The cellular and subcellular transfection of the modified polymers were evaluated
by using confocal imaging. Guanidine-modified CPs had shown better cellular uptake
and no cytotoxicity up to 40 μM concentration in HeLa cells. Selectively, one polymer
was chosen for gene delivery for the normal human epithelial cell (NHBE), known as the
primary cell line. Where gold-standard lipofectamine has failed to transfect NHBE cell,
we achieved a 20% siRNA knockdown and proven our hypothesis for a unique gene
delivery vehicle.
4.3. Result and Discussion

Figure 4.1. Plausible mechanism of guanidine head group modification[13]

Modified CP synthesis: As mentioned above, the primary goal of this research was
to make a modulated CP with a post-modification technique. Thus, we have chosen
guanidine-containing CP as a model polymer and modified its head group with various
functional compounds such as amines and alcohols. In Chapter 2, we discussed
modification of Boc-protected guanidine moiety and demonstrated the synthesis of
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antimicrobial polyamidinourea using catalyst-free direct modification chemistry.
Synthesized CPs are designated as follows: guanidine homo (PG-H), DIPA modified (PGD), morpholine modified (PG-M), piperidine modified (PG-P), and Aminoethoxyethanol
modified (PG-A). To synthesize various guanidine-modulated CPs, we started with DIPA
to make more hydrophobic polymer. The reaction condition was similar to conventional
the Sonogashira coupling reaction to synthesis PPE polymer, except the temperature
because 800C was the minimum requirement to deprotonate the amide proton in Bocguanidine and to incorporate DIPA. The modification reaction proceeds via generation of
isocyanate in situ. Figure 4.1 shows the possible reaction mechanism. Unlike PG-H, DIPA
has two isopropyl groups with secondary amine. We anticipated that PG-D would show
less charge on the surface and better solubility in organic solvent compared to PG-H.
Because the conjugated backbone between PG-H and PG-D were similar, we did not
observe any change in photo-physical properties between these two polymers (Table 4.1).
But we clearly observed a distinct difference in solubility and photo-physical behavior after
the Boc deprotection. PG-H was partially soluble in DMF and DMSO. However, PG-D
was completely soluble in DMF and DMSO. We also recorded changes in UV absorbance
and UV emission in water after the Boc deprotection. PG-H showed λmax = 408 nm
(95%water) and Fluoro λmax = 476 nm (95% water), whereas PG-D showed λmax = 417 nm
(95%water) and Fluoro λmax = 540 nm (95% water) (Figures 4.12 and 4.13). Being inspired
by this work, we chose morpholine as a more hydrophilic compound and modified PG-H
with morpholine using the post-polymerization technique. In this approach, PG-H were
heated with excess morpholine in the presence of tetrahydrofuran (THF) as a solvent at
800C overnight under N2 conditions. As expected, no change in photo-physical properties
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were observed with PG-M. But change was noted after the Boc deprotection. Improved
solubility and physical properties of PG-M were recorded and compared with PG-H. We
then moved on to piperidine and aminoethoxyethanol to modify the guanidine head group
and synthesize more hydrophobic and hydrophilic polymer PG-P and PG-A, respectively,
by following the post-polymerization technique. After deprotection of the Boc group, its
photo-physical data were recorded in DMSO and water. In water, UV absorbance and
emission were changed due to the modification with the hydrophilic and hydrophobic
moieties (Figure 4.14-4.16).
Table 4.1. Comparison of average physical and photo-physical properties of polymers
(PG-H, PG-D, PG-M, PG-P and PG-A)

Polymer
PG-H
PG-D
PG-M
PG-P
PG-A

a

n

20
14
14
14
15

Mn
(g/mol)b

PDI

13500
13000
12300
12400
13700

1.30
1.70
1.50
1.90
1.40

c

Yield
(%)d
65
62
76
53
79

λmax-

λmax-

abs

emission
e,f

(nm)e
434
418
435
435
434

(nm)
490
490
488
490
494

QYg

Hydrodynanic
diameter, nmh

8.30
8.14
8.20
8.37
19.8

274
298
283
291
162

a

Degree of polymerization. b Determined by gel permeation chromatography in THF. c PDI
(polydispersity index) = Mw/Mn. d Percent yield per repeating unit after repeated purification by
precipitation. e Measured in DMSO after Boc deprotection. f Measured in DMSO after Boc deprotection.
g
Quantum yield in DMSO after Boc deprotection. h Hydrodynamic diameter measured in PBS (0.2 μM)
after Boc deprotection.

Polymer characterization: All Boc-protected polymers are soluble in regular
organic solvents, such as DCM and tetrahydrofuran THF, and exhibit high molecular
weights and acceptable experimental yields, as listed in Table 4.1. After Boc deprotection
the polymer solubility was reduced, resulting in polymers soluble only in DMF and DMSO.
The experimental yields of PG-P were low due to the removal by precipitation of low-MW
fragments during the polymer purification process. The Proton NMR spectra of all
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polymers were consistent with their predicted average structure. Our analysis of predicted
polymer structures examined the ethoxy protons on the side chain of monomers A and B
(b ~4.23 ppm) and the guanidinum NH protons characteristic of monomer A (g ~ 12.4 ppm
and f ~ 8.2 ppm, respectively). As compared with PG-H, rest of the modified polymers
have shown only one Boc peak at 1.42 ppm, another confirmation of guanidine head group
modification. All proton peaks were integrated relative to the ethylene oxide proton peak
(b) and were in good agreement with the integration values predicted by the theoretical
head group modification analysis. Example spectra of PG-H and PG-D are presented in
Figure 4.2.

Figure 4.2. 1H NMR Comparison of guanidine head group modified polymer PG-H and
PG-D
Toxicity assay: The biocompatibility of the guanidine-modified CPs was evaluated
with the HeLa cell line for their use in gene delivery vehicle. Toxicity measurements were
carried out by Prakash Manandhar in my lab as a collaborator for this project. HeLA cells
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were selected for cytotoxic studies because they are durable and prolific and can be grown
easily in a 5% serum-supplemented standard DMEM medium with no specific growth
component requirement. The viability percentage of the cells was plotted against the CPs’
concentration at 48 hours (Figure 4.3). The concentration of CP up to 40 μM was not
cytotoxic.
.

Cell Viability %

100%

50%

0%
Control

5 uM

10 uM

20 uM

40 uM

Polymer concentration (μM)

Figure 4.3. Cell viability evaluation by MTT assay of PG-H. PG-H caused no viability
inhibition.
Cellular imaging: We evaluated the suitability of the modulated CPs as biological
markers through live cell imaging. Figure 4.4 shows the confocal images of HeLa cells
after incubation with the guanidine-modified series of polymers for 1 hour in a culture
medium at 10 μM. The cell nuclei were stained with 4’, 6-diamidino-2-phenylindole
(DAPI). These images were taken upon excitation at 488 nm (2.5 mW laser power) with a
650 nm long pass barrier filter. A higher fluorescence intensity is observed in Figure PGA than for the rest of the polymers. Thus, PG-A showed a higher quantum yield. The blue
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and green channels were used; based on the composite images, polymers were able to
penetrate the cell line, and some of them are co-stained with the nuclei.
Green channel

PG-M treated Cell

PG-D treated Cell

PG-H treated Cell

Control Cell

Blue channel
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Composite

PG-P treated Cell
PG-A treated Cell
Figure 4.4. Confocal images of HeLA cells incubated with Guanidine series of polymers
(10 μM for 1 h).
siRNA knockdown: Normal Human bronchial epithelial (NHBE) cells have a
different cellular membrane structure from HeLA cells and are difficult to transfect. Even
gold-standard transfection reagent lipofectamine was toxic to this cell line, and thus gene
delivery thorough NHBE cells was limited. PG-A was tested for siRNA delivery through
NHBE cells, and a maximum of 20% gene knockdown was achieved without killing the
cells. Figure 4.5 shows the siRNA knockdown data. This measurement was carried out by
Rajib Kumar Datta in Dr. Unwalla lab as a collaborator of this project.
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Figure 4.5. siRNA knockdown by PG-A in NHBE cell.
4.4.

Conclusion
We have described the design, synthesis, and cellular behavior of a new class of

guanidine-modified CPs. In this Chapter, we demonstrated successful synthesis of
guanidine-containing CP and head group modification of guanidine moiety in CPs with
various functional compounds. We also demonstrated that structurally diverse CPs can be
made using post-modification of guanidine moiety in CP. We proved that modified
polymers are well suited for gene or drug delivery because of their improved physical
properties.
4.5.

Outlook
Guanidine modification in small molecules has been reported, but we found no

studies in the case of polymers. This could be a new research field. A library of versatile
functional polymers can be made by following the post-modification method. At the same
time, a specific functional group can be attached with an existing guanidine CP to better
target a specific material.
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4.6. Experimental Section
4.6.1. Monomer Synthesis
Synthesis of guanidinum-containing aryl halide monomer A
Synthesis of guanidinum-containing aryl halide monomer A discussed in Chapter
2 Scheme 2.1.
Synthesis of Monomer B
Scheme 4.1. Synthesis of Guanidinum-containing acetylene monomer B

In an RBF charged with compound A (2.00 g, 1.96 mmol), trimethylsilylacetylene (0.77 g,
7.84 mmol), PdCl2(PPh3)2 (137.6 mg, 0.20 mmol), and CuI (18.6 mg, 0.10 mmol). The
RBF was evacuated and filled with N2. A solution of THF and DIPA was mixed in a 4:1
ratio (v/v) and degassed with N2 for 10 minutes, and 50 mL was transferred to the RBF via
a cannula. The reaction was stirred at r.t for 3 hours under an N2 balloon. The yellow
reaction mixture was filtered to remove insoluble particles and THF distilled out in vacuo.
The reaction mixture was dissolved in DCM and washed with 1M NH4Cl (2x) followed by
brine (1x). Column chromatography under 30% ethyl acetate in hexane yielded a final
product of a white solid (1.22 g, 65% yield).
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1

H NMR (400 MHz), CDCl3, δ: 11.46 (s, 1H), 8.67 (s, 1H), 7.21 (s, 1H), 4.1 (t, J = 4.4 Hz,

2H), 3.88 (t, J = 4.8 Hz, 2.H), 3.78 (t, J = 4.8 Hz, 2H), 3.66 (q, J = 5.2 Hz, 2H), 1.50 (s,
9H), 1.45 (s, 9H), 0.10 (s, 18H).
In an RBF, trimethylsilyl-protected compound (1.00 g, 1.04 mmol) and potassium
carbonate (0.36 g, 2.60 mmol) were dissolved in methanol (40 mL). The RBF was then
stirred at r.t. for 20 minutes. Upon confirmation by TLC, the solvent was dried in vacuo.
The reaction mixture was then purified in short-path column chromatography under 35%
ethyl acetate in hexane and yielded a final product of a yellowish solid (0.51 g, 60% yield).
1

H NMR (400 MHz), CDCl3, δ: 11.45 (s, 1H), 8.67 (s, 1.00H), 6.98 (s, 1H), 4.15 (t, J =

4.4 Hz, 2H), 3.86 (t, J = 4.8 Hz, 2H), 3.75 (t, J = 4.8 Hz, 2H), 3.65 (q, J = 5.2 Hz, 2H),
3.35 (s, 1H), 1.50 (s, 9H), 1.45 (s, 9H).

13

C NMR (400 MHz), CDCl3, δ: 156.4, 154.2,

153.1, 118.3, 113.8, 83.2, 83.1, 79.6, 79.4, 70.0, 69.8, 69.4, 40.9, 28.4, 28.2. FT-IR (neat):
3330.9, 3281.4, 2975.3, 2930.5, 1720.2, 1636.1, 1613.1, 1568.2, 1495.8, 1410.3, 1319.7,
1222.7, 1129.0, 1049.9 cm-1.
4.6.2. General procedure for guanidine homo polymer (PG-H)
Scheme 4.2 represents the synthetic procedure. A Schlenk flask was filled with monomer
A (50.0 mg, 0.04 mmol), B (40.0 mg, 0.04 mmol), PdCl2(PPh3)2 (3.43 mg, 0.005 mmol),
and CuI (0.47 mg, 0.003 mmol). The Schlenk flask was evacuated and filled with N2. A
solution of THF and DIPA was mixed in a 4:1 ratio (v/v) and degassed with N2, and 2.00
mL (volume) was transferred to the Schlenk flask via a cannula. The reaction was stirred
at r.t for 16 hours. The solution was then filtered through a glass wool pipette filter process
and transferred dropwise to methanol, resulting in precipitation. The supernatant was
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decanted, the precipitate was redissolved in DCM (0.50 mL), and the purification method
was repeated using methanol. The overall yield was 65% (26.9 mg). The resulting polymer
in DCM was characterized by gel permeation chromatography (GPC), and its
absorption/emission profiles were measured. The final polymer was allowed to dry under
a high vacuum for 16 hours before 1H NMR characterization.
Scheme 4.2. Synthesis of PG-H under the Sonogashira coupling condition

PG-H (Boc)
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Figure 4.6. UV absorbance and emission of Boc protected Guanidine Homo polymer
(PG-H)
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1

H NMR (400 MHz), CDCl3, δ: 11.46 (s, 1H), 8.62 (s, 1H), 7.05 (s, 1H), 4.24 (s, 2H), 3.91

(s, 2H), 3.74 (s, 2H), 3.62 (s, 2H), 1.48 (s, 9H), 1.45 (s, 9H). FT-IR (neat): 3329.4, 3131.7,
2975.3, 2931.3, 1720.1, 1635.2, 1614.0, 1567.7, 1503.9, 1411.8, 1364.5, 1319.8, 1280.5,
1249.7, 1131.0, 1048.8 cm-1. GPC: Mn = 13500 g/mol, Mw = 18000 g/mol, PDI = 1.30,
UV-Vis (THF) λmax = 442 nm, Fluo λmax = 469 nm.

Figure 4.7. 1H NMR Guanidine Homo polymer (PG-H)
PG-D (DIPA-modified CP): Using the general polymerization procedure described
above, the polymerization of monomers A (50.0 mg, 0.04 mmol) and B (40.0 mg, 0.04
mmol) in the presence of PdCl2(PPh3)2 (3.43 mg, 0.005 mmol), CuI (0.47 mg, 0.003 mmol),
THF, and DIPA (4:1) (v/v) were heated at 800C for 16 hours. The overall yield was 62%
(26.9 mg). The resulting polymer in DCM was characterized by GPC, and its
absorption/emission profiles were measured. The final polymer was allowed to dry under
a high vacuum for 16 hours before 1H NMR characterization.
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Scheme 4.3. Synthesis of PG-D under the Sonogashira coupling condition

1

H NMR (400 MHz), CDCl3, δ: 12.42 (s, 1H), 8.21 (s, 1H), 7.05 (s, 1H), 4.23 (s, 2H),

3.90 (s, 2H), 3.75 (s, 4H), 3.60 (s, 1H), 3.54 (s, 2H), 1.42 (s, 9H), 1.23 (s, 12H) FT-IR
(neat): 3338.6, 3139.9, 2964.5, 2828.5, 2763.8, 2712.9, 2454.9, 2398.4, 1714.2, 1666.8,
1628.9, 1574.1, 1432.9, 1395.8, 1337.0. GPC: Mn = 13200 g/mol, Mw = 22400 g/mol, PDI
= 1.70, UV-Vis (THF) λmax = 434 nm, Fluo λmax = 472 nm.

Figure 4.8. 1H NMR Guanidine DIPA (PG-D)
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PG-M (Morpholine-modified CP): A Schlenk flask was charged with PG-H (10.0
mg, 0.012 mmol) and morpholine (2.57 mg, 0.03 mmol). The Schlenk flask was evacuated
and filled with N2. Degassed THF (1.5 mL) was transferred to the Schlenk flask via a
cannula. The reaction was stirred at 800C for 16 hours. A viscous polymer solution purified
by a glass wool filtration followed re-precipitation in diethyl ether and then in methanol.
The final polymer was a yellow gel (7.72 mg with 76% yield).
Scheme 4.4. Synthesis of Guanidine head group modified polymers (PG-M, PGP, and PG-A)

1

H NMR (400 MHz), CDCl3, δ: 12.2 (s, 1H), 8.3 (s, 1H), 7.04 (s, 1H), 4.22 (s, 2H), 3.90

(s, 2H), 3.74 (s, 4H), 3.60 (s, 4H), 3.52 (s, 4H), 1.42 (s, 9H). FT-IR (neat): 3331.3, 2925.8,
2857.0, 1716.2, 1669.7, 1629.8, 1585.9, 1562.7, 1507.5, 1475.2, 1454.3, 1409.6, 1366.4,
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1348.9, GPC: Mn = 12400 g/mol, Mw = 18600 g/mol, PDI = 1.50. UV-Vis (THF) λmax =
428 nm, Fluo λmax = 469 nm.

Figure 4.9. 1H NMR Guanidine Morpholine (PG-M)
PG-P (Piperidine-modified CP): A Schlenk flask was charged with PG-H (10.00
mg, 0.012 mmol) and piperidine (2.51 mg, 0.03 mmol). The Schlenk flask was evacuated
and filled with N2. Degassed THF (1.5 mL) was transferred to the Schlenk flask via a
cannula. The reaction was stirred at 800C for 16 hours. A viscous polymer solution purified
by glass wool filtration followed re-precipitating in diethyl ether and then in methanol. The
final polymer was a yellow gel (5.36 mg with 53% yield).
1

H NMR (400 MHz), CDCl3, δ: 12.30 (s, 1H), 8.22 (s, 1H), 7.05 (s, 1H), 4.22 (s, 2H), 3.90

(s, 2H), 3.74 (s, 2H), 3.65 (s, 2H), 3.59 (s, 1H), 3.53 (s, 2H), 3.47 (s, 2H) 1.42 (s, 9H). FTIR (neat): 3332.9, 2929.9, 2853.7, 1714.7, 1666.8, 1630.8, 1583.8, 1560.5, 1475.5, 1423.6,
1365.9, 1253.2. GPC: Mn = 14600 g/mol, Mw = 27800 g/mol, PDI = 1.90. UV-Vis (THF)
λmax = 436 nm, Fluo λmax = 461 nm.
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Figure 4.10. 1H NMR Guanidine Piperidine (PG-P).
PG-A (Aminoethoxyethanol-modified CP): A Schlenk flask was charged with PGH (10.0 mg, 0.012 mmol) and aminoethoxyethanol (3.10 mg, 0.03 mmol). The Schlenk
flask was evacuated and filled with N2. Degassed THF (1.5 mL) was transferred to the
Schlenk flask via a cannula. The reaction was stirred at 800C for 16 hours. A viscous
polymer solution purified by glass wool filtration followed re-precipitating in diethyl ether
and then in methanol. The final polymer was a yellow gel (8.20 mg with 79% yield).
1

H NMR (400 MHz), CDCl3, δ: 12.05 (s, 1H), 8.27 (s, 1H), 7.04 (s, 1H), 6.03 (s, 1H), 4.22

(s, 2H), 3.90 (s, 2H), 3.72 (s, 5H), 3.53 (s, 8H), 3.36 (s, 2H), 1.42 (s, 7H). FT-IR (neat):
3323.5, 2929.8, 2870.9, 1716.7, 1633.2, 1597.8, 1507.7, 1453.7, 1411.0, 1347.9, 1311.7,
1277.2, 1227.2. GPC: Mn = 13800 g/mol, Mw = 19600 g/mol, PDI = 1.40. UV-Vis (THF)
λmax = 435 nm, Fluo λmax = 465 nm.

91

Figure 4.11. 1H NMR Guanidine Aminoethoxyethanol (PG-A)
4.6.3. General procedure for Boc deprotection of modified CPs
In a vial, Boc-protected polymer was dissolved in DCM (1.00 mL) and TFA (1.00 mL) and
stirred at r.t for 48 hours. Precipitation in DCM confirmed the complete Boc deprotection
and solvent evaporated in vacuo. TFA was removed by azeotrope distillation and
deprotected polymer purified by re-precipitating in EA(2x). After drying in a high vacuum,
Boc deprotection was confirmed by 1H NMR.
PG-H: Following the general procedure described above, the final deprotected
polymer was a yellow gel (74.6 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 8.13 (s, 1H), 7.92 (s, 2H), 7.27 (s, 2H), 6.87 (s, 1H),

5.77 (s, 1H), 5.03 (s, 1H), 4.30 (s, 2H), 3.98 (s, 2H), 3.59 (s, 4H), 3.50 (m, 6H), 2.98
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(m,10H), 2.87 (s, 1H), 2.01 (m, 6H). FT-IR (neat): 3360.36, 2160.37, 1736.79, 1681.18
cm-1. UV-Vis (DMSO) λmax = 434 nm, Fluo λmax = 490 nm, QY = 8.30.

Figure 4.12. Absorption and emission spectra of PG-H in DMSO (left) and 95% water
(right).
PG-D: Following the general procedure described above, the final deprotected
polymer was a yellow gel (72.5 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 9.73 (s, 1H), 9.27 (s, 1H), 8.65 (s, 2H), 7.5 (s, 2H),

4.62 (s, 2H), 4.4 (s, 2H), 4.03 (s, 2H), 3.76 (s, 4H), 3.56 (s, 2H), 3.50 (m, 6H), 1.17 (m,
13H). FT-IR (neat): 3512.0, 2994.8, 2992.6, 2159.87, 1733.97, 1679.4 cm-1. UV-Vis
(DMSO) λmax = 418 nm, Fluo λmax = 490 nm, QY = 8.14.

Figure 4.13. Absorption and emission spectra of PG-D in DMSO (left) and 95% water
(right).
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PG-M: Following the general procedure described above, the final deprotected
polymer was a yellow gel (62 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 10.2 (s, 1H), 9.20 (s, 2H), 8.60 (br s, 2H), 7.55 (s,

3H), 4.38 (br s, 4H), 4.10 (s, 2H), 3.80 (br s, 4H), 3.53 (br m, 11H), 3.59 (s, 4H). FT-IR
(neat): 3280.78, 2872.4, 1670.82, 1440.13, 1303.92, 1251.30, 1198.86 cm-1. UV-Vis
(DMSO) λmax = 435 nm, Fluo λmax = 488 nm, QY = 8.20.

Figure 4.14. Absorption and emission spectra of PG-M in DMSO (left) and 95% water
(right).
PG-P: Following the general procedure described above, the final deprotected
polymer was a yellow gel (66.4 % yield).
1

H NMR (400 MHz, DMSO-d6, δ): 10.03 (s, 1H), 9.25 (s, 1H), 8.60 (s, 2H), 7.53 (s, 2H),

4.38 (s, 1H), 4.03 (s, 1H), 3.81 (s, 2H). FT-IR (neat): 3305.85, 2940.75, 1667,98, 1444.67,
1252.02, 1198.52 cm-1. UV-Vis (DMSO) λmax = 435 nm, Fluo λmax = 490 nm, QY = 8.37.
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Figure 4.15. Absorption and emission spectra of PG-P in DMSO (left) and 95% water
(right).
PG-A: Following the general procedure described above, the final deprotected
polymer was a yellow gel (79% yield).
1

H NMR (400 MHz, DMSO-d6, δ): 10.03 (s, 1H), 9.25 (s, 1H), 8.60 (s, 2H), 7.53 (s, 2H),

4.38 (s, 1H), 4.03 (s, 1H), 3.81 (s, 2H). FT-IR (neat): 3267.35, 2872.85, 1788.01, 1670.04,
1547.08, 1447.00, 1346.70, 1199.44. UV-Vis (DMSO) λmax = 434 nm, Fluo λmax = 494 nm,
QY = 19.81.

Figure 4.16. Absorption and emission spectra of PG-A in DMSO (left) and 95% water
(right).
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Scheme 4.5. Synthetic route toward precursor compound 3

Compound 2 was synthesized according to the literature [1]. More specifically, H5IO6 (29.2
g, 130 mmol) and 200 mL methanol were added to an RBF and stirred for 10 minutes to
make a solution. Later, I2 (63.8 g, 250 mmol) was added to the RBF and made into a
solution through stirring. Compound 1 (27.0 g, 190 mmol) was added to the RBF and left
a reflux condition stirred in the flask overnight. Next day the reaction mixture was
quenched into Na2S2O5, and the resultant precipitate was filtered through vacuum filtration.
The powder product on the filter paper was washed with water, methanol, and DCM. The
organic layer was distilled off and filtered again to get the expected product 2 (63.0 g, 85%
yield).
Compound 3 (Scheme 2.5): Compound 3 was synthesized according to the literature[1].
Basically, compound 2 (33.1 g, 79.8 mmol) was dissolved in DCM (300 mL) degassed
with a stream of N2 for 15 minutes, and the mixture was placed in an ice/water bath. BBr3
(100 g, 399 mmol) was added, and the reaction mixture was allowed to stir at r.t. overnight.
The reaction was quenched with a DCM/methanol mixture and concentrated in vacuo. The
resulting solid was washed with DCM on a Buchner funnel. Compound 3 was obtained as
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a light beige solid (26.7 g, 87 %). 1H NMR (400 MHz, DMSO-d6): δ 9.80 (s, 2H), 7.14 (s,
2H)
Scheme 4.6. Synthetic route toward precursor compound 5

Compound 4 (Scheme 4.6): Compound 4 was synthesized according to the literature[15].
More specifically, aminoethoxyethanol (20.0 g, 95.1 mmol) was dissolved in DCM (300
mL) in an RBF. Di-tert-butyl decarbonate (Boc2O) (39.4 g, 90.4 mmol) was dissolved in
DCM (200 mL) and placed in an additional funnel. The solution was added dropwise
during stirring, and the reaction was allowed to stir at r.t. overnight. The reaction was
quenched with H2O; the two layers were separated, and the organic layer was washed with
H2O and brine, dried over Na2SO4, and concentrated in vacuo to yield compound 4 as a
colorless oil (34.6 g, 93%). 1H NMR (400 MHz, CDCl3): δ (br s, 1H), 1.43 (s, 9H)
Compound 5 was synthesized according to the literature[16]. More specifically, compound
4 (33.9 g, 165 mmol), tosyl chloride (31.5 g, 165 mmol), triethylamine (46.1 mL, 330
mmol), and DCM (500 mL) were reacted according to the procedure for the preparation of
compound 5 above. Following extraction, the crude mixture was recrystallized from the
THF/ether solvent system to yield compound 5 as a white solid (41.7 g, 70%).
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1

H NMR (400 MHz, CDCl3): δ 7.82 (d, 2H, J = 8.34 Hz), 7.36 (d, 2H, J = 8.08 Hz), 4.81

(br s, 1H), 4.18-4.16 (m, 2H), 3.65-3.63 (m, 2H), 3.46 (t, 2H, J = 5.31 Hz), 3.25 (q, 2H, J
= 4.97 Hz), 2.46 (s, 3H), 1.46 (s, 9H)
Scheme 4.7. Synthetic route toward precursor compound 7

Compound 6 (Scheme 4.7): Following the synthetic procedure for compound 5, the
reaction of compound 3 (8.00 g, 22.1 mmol), compound 5 (17.5 g, 46.6 mmol), and
potassium carbonate (12.2 g, 88.4 mmol) produced a crude product, which was purified by
recrystallization from ethyl acetate to yield compound 6 as a beige crystalline solid (9.4 g,
58%).
1

H NMR (400 MHz, CDCl3): δ 7.30 (s, 1H), 5.06 (br s, 1H), 4.13 (t, 2H, J = 4.55 Hz), 3.87

(t, 2H, J = 4.80 Hz), 3.69 (t, 2H, J = 5.05 (Hz), 3.40-3.39 (m, 2H), 1.48 (s, 9H)
Compound 7 (Scheme 4.7): Compound 7 was synthesized according to the literature[14].
More precisely, in an RBF, compound 6 (4.52 g, 6.14 mmol) was dissolved in DCM (100
mL). Trifluoroacetic acid (TFA) (3.50 g, 30.7 mmol) was added to the RBF and stirred at
r.t. overnight. The reaction mixture was concentrated in vacuo and dissolved in ethyl
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acetate. Triethylamine was added to make the pH 7 and resulted in precipitation. The
precipitate was collected through vacuum filtration and dried over a high vacuum to yield
compound 7 as a beige crystalline solid (2.90 g, 90%). 1H NMR (400 MHz, DMSO-d6): δ
7.87 (s, 2H), 7.38 (s, 1H), 4.13 (t, 2H, J = 4.55 Hz), 3.80 (t, 2H, J = 4.80 Hz), 3.72 (t, 2H,
J = 5.05 (Hz), 3.10 (m, 2H).
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CHAPTER V
GENERAL CONCLUSIONS
Antimicrobial polymers have been gaining in prominence because of their low
tendency to cause drug-resistant pathogens. Synthetic polymers have emerged as
promising antimicrobial candidates in combating resistant bacteria over the last few years.
Understanding bacterial cell walls, cytoplasmic membranes, and outer membranes, we
designed a smart design of monomers and polymers and a great development on synthesis
of antimicrobial polymers called polyaminorea has been achieved. The majority of
polyamidinourea is composed of cationic and is hydrophobic in nature, and their
bactericidal properties regarding the physical membrane disruption of the bacteria cell wall
was evaluated using various methods. More precisely, we presented in Chapter 2 a novel
method for synthesis of polyamidinoure containing antimicrobial polymer and their
biological properties. In Chapter 3, we focused on Cipro-containing homo and block
copolymer synthesis using ring-opening metathesis polymerization (ROMP).
We discussed synthesis of guanidine-modified conjugated polymers (CPs) in
Chapter 4, as well as the novel method to develop a series of CPs by the postpolymerization technique. We tested synthesized CPs in the development of a CP-based
gene or drug delivery system.
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